补肾活血方干预肾虚血瘀型卵巢储备功能下降之月经后期、过少的临床研究
|
摘要
目的意义：卵巢储备功能（Ovarian Reservation，OR）是指卵巢皮质区卵泡生长、发育、形成可受精卵泡的能力。因此生殖功能的衰退表现为皮质区内的卵泡内卵母细胞储存的质量和数量下降，这也是卵巢储备功能下降（Decreasing Ovarian Reservation，DOR）的基本内涵[1]。近年来，随着社会的发展，文化观念、生活环境、工作压力等的改变，使DOR发病率有逐年上升趋势，严重影响着女性的生殖健康和生活质量，而现有国内高等院校中西医统编教材中并无DOR病症的专门论述，所涉及内容偶见于闭经、不孕症、围绝经期综合征中，相关的文献报道也甚少，更缺乏系统、全面的理论阐述和规范、具有指导意义的临床证治路径，因此，我们根据辨证论治，以中医基础理论、相关临床疗效观察为依据，用现代科学的理念和方法阐释补肾活血方干预肾虚血瘀型DOR之月经后期、过少的效应机理，探讨补肾活血法有效干预肾虚血瘀型DOR的临床证治规律，为中医药有效治疗DOR提供科学依据。
研究方法：在我们既往单味黄芪对排卵障碍大鼠的干预机制研究中显示炙黄芪对女性排卵、内分泌治疗疗效明显，本研究继前优势遂组成以炙黄芪、菟丝子为君药的补肾活血方再次进行了理论及临床研究:分三部分。第一部分“DOR的文献研究”，根据翻阅古籍经典，结合近现代临床和实验研究成果，研究了卵巢储备功能的中西医研究现状及其进展。第二部分“DOR的中医证候分布研究”，根据中医辨病标准分析其中医病种归属，参照中医证候辨证标准判断其中医证候类型，分析探讨其中医证候特征。第三部分“补肾活血方干预肾虚血瘀型DOR之月经后期、过少的临床研究”，研究补肾活血方干预肾虚血瘀型DOR之月经后期、过少的有效性，观察DOR患者运用补肾活血方治疗前后症状和体征积分，基础FSH，LH，E2，FSH/LH，抑制素B，抗苗勒管激素，窦卵泡计数、卵巢体积、卵巢间质动脉血流速度峰值（PSV）、阻力指数（RI）、搏动指数（PI）等指标的改变。
研究结果：
（一）卵巢储备功能下降的中医证候分布调查研究结果：1.研究表明患者主诉症状出现率以不孕、月经量少、月经周期错后为主。2.中医诊断中，月经过少、月经后期、不孕症居多。在主诉症状排序中，“不孕”排序在第一位，而在中医诊断排序中，“不孕”排序在第三位。究其原因，考虑为与患者心理有关。在较多患者认为，月经量少甚至月经后期，都不影响正常生活，且无关痛痒，不对身体造成明显的不适感，故而其带来的不适不足以引起重视。由于千百年来中国人对“传嗣”的重视，导致女性对“孕育”极其敏感。部分患者认为，一旦开始备孕，就应该短时间内受孕。故而我们在临床常见备孕半年以内未受孕，而前来就诊者，说明患者对孕育的关注程度，远高于月经不调对患者造成的影响。3.证型分布以肾虚血瘀、肾虚肝郁、气滞血瘀为主。通过研究显示中医对卵巢储备功能下降的基本病因归为“肾虚、血瘀、肝郁”，本研究通过对卵巢储备功能下降患者主诉、中医诊断及辨证情况进行分析统计，月经改变是巢储备功能下降最首要的外在表现，从而可知“月经后期”、“月经过少”是卵巢储备功能下降的两个典型症状，临床常同时并存，逐渐发展，最后可致闭经。鉴于目前尚无判断卵巢储备功能下降的诊断金标准，现有的诊断标准无法明确其程度与分期，故此次研究只是小样本的临床探讨，只能说明部分卵巢储备功能下降患者的特征，不能整个囊括月经紊乱的规律，还待大样本临床探讨。
（二）补肾活血方干预肾虚血瘀型卵巢储备功能下降之月经后期、过少的临床研究结果：补肾活血方对卵巢储备功能下降之月经后期、过少患者的临床症状有明显的改善作用，中药组总有效率及显效率与西药组相比无显著差异（P>0.05）。说明在治疗DOR的临床疗效上，补肾活血方与西药克龄蒙功效相当。在治疗过程中中药组有2人不孕症患者妊娠，多次体外受精-胚胎移植失败的1人成功助孕，由此可知补肾活血方（法）在治疗不孕症方面占据优势。在改善DOR患者中医证候上，中药组、西药组均取得非常好的疗效（p＜0.01）。两组间比较，补肾活血方比克龄蒙效果更佳（p＜0.01），说明在改善DOR患者证候上，中西医均有效，且中药组效果更显著。停药3个月后，中药组、西药组治疗前后有显著性差异，而空白组与上述两组治疗后比较有显著性差异，说明药物可以改善卵巢储备功能下降患者的症状，并且中药组短期综合疗效明显。中药组治疗前后各项症状积分相比，均有非常显著性差异（p＜0.01），表明了补肾活血方可以明显改善DOR患者的各项临床症状，体现了补肾活血方的补肾、养血、活血功效。西药组治疗前后各项症状积分相比，在改善月经延后、色暗有块、潮热汗出、性欲减退方面，有非常显著性差异（p＜0.01），说明克龄蒙可以改善DOR患者月经量少及雌激素下降引起的类绝经期症状；却不能改善腰骶酸痛、头晕耳鸣等症状（p＞0.05）。中药组在改善DOR患者腰骶酸软、头晕耳鸣等肾虚方面疗效更佳卓著，体现补肾活血方的补肾功效；在改善月经量少、色暗有块方面有显著性差异（p＜0.05），提示中药与西药相比在改善DOR患者经量、经质时效果明显，可能系中药组活血、养血药物调节脏腑功能之体现；在改善月经延后、潮热汗出、性欲减退方面无显著性差异（p＞0.05）。经Ridit分析（以两组合并作为标准组），中药组患者调经疗效优于西药组。补肾活血方对性激素水平有一定的调节作用，补肾活血方、克龄蒙均可明显改善DOR患者的激素水平。在LH方面有显著性差异（P<0.05），而其他方面无显著性差异，说明激素水平调节方面，中药组与西药组大致相当，仅仅在LH方面略显优势。治疗后中药组、西药组分别与3个月后空白组FSH、LH、FSH/LH、E2比较，均有非常显著性差异（P<0.01）。中西药均可以上调卵巢颗粒细胞抑制素B蛋白、抗苗勒氏管激素(AMH)的表达，改善卵巢储备功能（P<0.01）。阴式B超检查中AFC、PSV、PI、RI方面有非常显著性差异（P<0.05），补肾活血方在增加窦卵泡数、改善卵巢血供（PSV、PI、RI）上效果优于西药组。以上说明补肾活血方对卵巢储备功能下降具有良好的临床疗效，并且它的短期综合疗效明显优于西药组，短期综合疗效较稳定。
结论：①通过小样本卵巢储备功能下降患者的中医证候分布研究显示卵巢储备功能下降患者的中医证型以肾虚血瘀、肾虚肝郁居多，月经改变是巢储备功能下降最首要的外在表现，“月经后期”、“月经过少”是卵巢储备功能下降的两个典型症状。另一方面，“月经后期”、“月经过少”作为中医治疗月经病的难点问题之一，如何通过中医药治疗，改善月经量、调整月经周期，是本研究的主要目的。②补肾活血方干预肾虚血瘀型DOR之月经后期、过少的效应机理可能通过干预调节生殖激素、抑制卵巢颗粒细胞凋亡、促进卵巢血管生成而实现。③肾虚血瘀型DOR的主要临床症状为月经延后，月经量少，色暗有块，小腹痛，块下痛减，腰骶酸痛、头晕耳鸣、潮热汗出、性欲减退。舌淡或紫暗边有瘀斑，脉沉细或沉涩。④补肾活血方干预肾虚血瘀型DOR之月经后期、过少的短期疗效明显优于单纯西药治疗，合理运用补肾活血方干预DOR，疗效显著，对预防、延缓POF的发生具有非常积极的意义，从而可以提高女性生活质量。⑤基础血FSH、LH、FSH/LH、E2、INHB和AMH及经阴道B超检查中的卵巢体积、AFC、PSV、PI、RI可作为临床诊断、评估DOR的可靠辅助检查指标。⑥依据中医“治未病”的理论，在卵巢功能储备功能下降的疾病发展过程中，DOR可认为是POF的“未病”阶段，POF是“已病”阶段。所以通过临床症状及实验室检查尽早发现DOR，运用“治未病”的观点指导我们在整个治疗过程中的遣方用药，积极干预，中断发展趋势。
PURPOSE: The ovarian reserve function (Ovarian Reservation， OR)refers to the ability of ovarian cortex follicle growth anddevelopment， forming a fertilized follicles. Therefore，reproductive function recession is the quality and quantity of theoocyte cortex follicles stored down，this is the diminished ovarianreserve (Decreasing Ovarian Reservation， DOR) of the basicconnotation of. In recent years， with the development of society，culture， living environment， work pressure and other changes，the incidence of DOR increased year by year， seriously affectingwomen's reproductive health and quality of life. But the existingdomestic universities and medical textbook are not poor ovarianreserve function disorder of the devoted， The content ofoccasionally in amenorrhea，infertility，menopause syndrome，therelevant literature is also very little，clinical treatment pathlack systematic， comprehensive theoretical explanation andsignificance，the specification. Therefore， we according tosyndrome differentiation and treatment，on the basis of the clinicalcurative effect of TCM basic theory. Using the idea and method of modern scientific explanating effect mechanism of BushenhuoxueFang treatment of kidney deficiency and blood ovarian reservedecline in the late menstruation. To investigate the clinicaltreatment of tonifying the kidney and promoting blood circulationand effective intervention of kidney deficiency and blood stasistype of diminished ovarian reserve，to provide scientific basis forthe traditional Chinese medicine is effective in the treatment ofdiminished ovarian reserve.
METHODS：Research on intervention mechanism of previous singlemedicine Astragalus on anovulatory rats showed astragalus rootobviously curative effect for female ovulation, endocrine therapy.In this study, following the first advantage and compositionconsists of astragalus root and dodder Bushen Huoxue Fang once againconducted clinical and theoretical research: This text is dividedinto three parts. The first part“Study of traditional literaturediminished ovarian reserve”，According to reading books classics,combined with modern clinical and experimental research, thecurrent research situation and development of traditional Chinesemedicine and Western Medicine on ovarian reserve function. Thesecond part“Study on the distribution of TCM Syndromes of DOR”，According to the analysis of the traditional Chinese medicinedisease belong todisease differentiation criteria of traditionalChinese medicine, according toTCM differentiation standard tojudge its TCM syndrome types, analysis to explore thecharacteristics of TCM Syndromes. The third part “the ClinicalResearch of Bushenhuoxue Fang in Treating Kidney Deficiency andBlood Stasis Menopathy result from declining ovarian reserve”，study Validity of Bushenhuoxue Fang in Treating Kidney Deficiency and Blood Stasis Menopathy result from declining ovarian reserve，Observation of DOR patients by Bushenhuoxue Fang before and afterthe treatment， the symptoms and signs of integral，to study Changeof the level changes of blood basis of FSH， LH， FSH/LH and E2，INHB， AMH，AFC，the volume of ovary，PSV，RI，PI，Etc.
RESULTS:The first part：The decline of ovarian reserve functionof distribution of TCM Syndromes of survey results:①Research showsthat the symptoms of patients with infertility rate, menstruation,menstrual cycle after the fault.②The Chinese medicine diagnosis,menstruation, menstruation, infertility. The symptoms sort,"infertility" ranking in the first place, and in the diagnosis ofTCM sort,"infertility" ranking in third. Investigate its reason,considered as related to mental patients. Think in more patients,menstruation or menstrual period, do not affect normal life, andbe of no importance, not cause obvious discomfort, so its discomfortis not sufficient attention. Since thousands of years Chinese on"people" attention, resulting in women is extremely sensitive tothe "birth". Some patients think, once begin to prepare forpregnancy; it should be a short time insemination. Therefore wecommon pregnant within six months of non pregnancy in clinical, andcame to visit, the patient attention to inoculation, far higher thanthe irregular menstruation effect on patients caused by.③Syndromedistribution to kidney deficiency and blood stasis, kidneydeficiency and liver qi stagnation, Qi and blood stasis. Throughthe research shows the basic cause Chinese descent on ovarianreserve function as "kidney deficiency, blood stasis, stagnationof liver qi", menstrual change is the nest functional reserveexternal performance the most important, is directly reflect the decline in female fertility, through the study on the ovarianreserve function decline, the patient complained of TCM diagnosisand syndrome differentiation were analyzed statistically, thus the"late period","menstruation" is the decline of ovarian reservefunction of two typical symptoms, clinical often coexist at the sametime, develop gradually, and finally can cause amenorrhea. In viewof the fact that there is no judgment the diagnostic gold standarddiminished ovarian reserve, the existing diagnostic criteria cannot clear the extent and staging, this study is the small sampleclinical study, can only explain part of the diminished ovarianreserve patient characteristics, not the whole encompassingmenstrual disorder rules, also be big sample clinical study.Thesecond part：Results of the clinical research of bushenhuoxue fangin treating kidney deficiency and blood stasis menopathy resultfrom declining ovarian reserve：①The clinical symptoms of "BushenHuoxue Fang on menstrual ovarian function decline, too late"patients have obvious improvement, traditional Chinese medicinegroup total effective rate and significant efficiency and thewestern medicine group showed no significant difference (P>0.05).The clinical efficacy in the treatment of DOR, effect of BushenHuoxue Decoction and Western medicine Climen effect is equivalentto. In the course of treatment of traditional Chinese medicine group,pregnancy2infertility patients,1person times of in vitrofertilization and embryo transfer failure success helps is pregnant,so the Bushen Huoxue Fang (Law) occupy the advantage in thetreatment of infertility.②In improving the TCM syndrome inpatients with DOR syndrome, traditional Chinese medicine group,western medicine group has very good curative effect (P<0.01). The comparison between two groups, better than the effect of BushenHuoxue Climen (P<0.01), in the patients with DOR syndrome,traditional Chinese medicine and Western medicine are effective,and the traditional Chinese medicine group has more remarkableeffect.3months after drug withdrawal, there was significantdifference before and after the Chinese medicine group, westernmedicine treatment group and blank group, and the two groups aftertreatment were significant difference, the medicine can improve thesymptoms of patients with diminished ovarian reserve, and thetherapeutic effect of traditional Chinese medicine group was short.③Compared with the Chinese medicine group before and aftertreatment the symptom integral, there was significant difference(P<0.01), show that the effect of Bushen Huoxue Decoction cansignificantly improve the clinical symptoms of the patients withDOR, the effect of Bushen Huoxue Decoction of invigorating thekidney, nourishing the blood, promoting blood circulation effect.Compared with the western medicine group before and after treatmentthe symptom integral, in the improvement of delayed menstruation,color block, hectic fever and sweating, hyposexuality, there wasa significant difference (P<0.01), explain Climen can improvepatients with DOR menstruation and menopause syndrome caused bydecreased estrogen class like; but does not improve the lumbosacralpain, dizziness tinnitus symptoms (P>0.05). Traditional Chinesemedicine group in improving DOR in patients with lumbosacral achingand limp, dizziness and tinnitus, kidney deficiency on bettercurative effect, embodies the Bushen Huoxue Fang kidney; inimproving menstrual quantity is little, there is a dark color withsignificant difference (P<0.05), suggesting that traditional Chinese medicine and Western medicine in patients with DOR comparedto the volume, the matter, obviously, traditional Chinese medicinegroup and activating blood, nourishing the blood may reflect theinternal organs function of drug regulation; there was nosignificant difference in the improvement of delayed menstruation,hectic fever and sweating, hyposexuality aspects (P>0.05).④By theanalysis of Ridit (the two together as the standard group), Chinesemedicine group is better than western medicine group menstruation.⑤Effect of Bushen Huoxue decoction has certain effect onregulating the levels of sex hormones, Bushen Huoxue Fang, Climencould significantly improve the hormone levels in patients with DOR.There were significant differences in LH (P<0.05), but nosignificant difference in other aspects, the hormone levelregulation, traditional Chinese medicine group and Westernmedicine group is roughly equal, only slightly in the LH advantage.After the treatment of traditional Chinese medicine group andWestern medicine group, respectively, and3months after the blankgroup FSH, LH, FSH/LH, E2, there was significant difference(P<0.01).⑥Chinese and Western medicine could increase ovariangranulosa cell inhibin B protein, anti Mullerian hormone (AMH)expression, improve the ovarian reserve function (P<0.01).⑦Therewas a significant difference between female B ultrasoundexamination in AFC, PSV, PI, RI (P<0.05), Bushen Huoxue Fang on theincreasing number of antral follicles, improve the ovarian bloodsupply (PSV, PI, RI) is better than western medicine group. Theeffect of Bushen Huoxue decoction has good curative effect onovarian reserve function decline, and short-term therapeuticeffect of it is better than medicine group, short-term curative effect is stable.
CONCLUSION：①Through a small sample of diminished ovarian reservedistribution of TCM Syndromes of patients showed a decline inovarian reserve function of TCM syndromes in patients with kidneydeficiency and blood stasis, kidney deficiency and liver stagnationin multiple, menstrual change is the nest functional reserveexternal performance the most important,"late period","menstruation" is the decline of ovarian reserve function twotypical symptoms. On the other hand,"late period","menstruation"as the Chinese medicine treatment of menstrual disease one of themost difficult issues, how to improve the treatment of traditionalChinese medicine, menstrual quantity, adjust the menstrual cycle,is the main purpose of this study.②Effects and mechanism of BushenHuoxue Fang intervention menstrual blood stasis DOR, too late mayinterfere with the regulation of reproductive hormones, inhibit theapoptosis of ovarian granulosa cells of ovary, promote angiogenesisand implementation.③The main clinical symptoms of kidneydeficiency and blood stasis type DOR for delayed menstruation,menstrual quantity is little, there is a dark color, small abdominalpain, block alleviation of pain, lumbosacral pain, dizziness andtinnitus, hectic fever and sweating, sexual hypoesthesia. Paletongue or dark purple edge petechiae, pulse small or astringent.④Short term effect of Bushen Huoxue Fang intervention menstrualblood stasis DOR, too late is better than pure western medicinetreatment, rational use of Bushen Huoxue Fang intervention DOR,obvious curative effect, to prevent the occurrence of POF, delayis a very positive meaning, which can improve the quality of lifeof women.⑤Based on FSH, LH, FSH/LH, blood E2, INHB and AMH and transvaginal B ultrasound examination of the ovarian volume, AFC,PSV, PI, RI can be used as a reliable auxiliary examination indexof clinical diagnosis, assessment of DOR.⑥According totraditional Chinese medicine "preventive treatment of disease"theory, course of the disease decline in ovarian reserve function,DOR can be considered to be POF "no disease" stage, POF is "disease"stage. So based on the clinical symptoms and laboratory examinationto find DOR, the use of "preventive treatment of disease" point ofview to guide us in the whole course of treatment of the prescription,active intervention, interrupt the development trend.
研究方法：在我们既往单味黄芪对排卵障碍大鼠的干预机制研究中显示炙黄芪对女性排卵、内分泌治疗疗效明显，本研究继前优势遂组成以炙黄芪、菟丝子为君药的补肾活血方再次进行了理论及临床研究:分三部分。第一部分“DOR的文献研究”，根据翻阅古籍经典，结合近现代临床和实验研究成果，研究了卵巢储备功能的中西医研究现状及其进展。第二部分“DOR的中医证候分布研究”，根据中医辨病标准分析其中医病种归属，参照中医证候辨证标准判断其中医证候类型，分析探讨其中医证候特征。第三部分“补肾活血方干预肾虚血瘀型DOR之月经后期、过少的临床研究”，研究补肾活血方干预肾虚血瘀型DOR之月经后期、过少的有效性，观察DOR患者运用补肾活血方治疗前后症状和体征积分，基础FSH，LH，E2，FSH/LH，抑制素B，抗苗勒管激素，窦卵泡计数、卵巢体积、卵巢间质动脉血流速度峰值（PSV）、阻力指数（RI）、搏动指数（PI）等指标的改变。
研究结果：
（一）卵巢储备功能下降的中医证候分布调查研究结果：1.研究表明患者主诉症状出现率以不孕、月经量少、月经周期错后为主。2.中医诊断中，月经过少、月经后期、不孕症居多。在主诉症状排序中，“不孕”排序在第一位，而在中医诊断排序中，“不孕”排序在第三位。究其原因，考虑为与患者心理有关。在较多患者认为，月经量少甚至月经后期，都不影响正常生活，且无关痛痒，不对身体造成明显的不适感，故而其带来的不适不足以引起重视。由于千百年来中国人对“传嗣”的重视，导致女性对“孕育”极其敏感。部分患者认为，一旦开始备孕，就应该短时间内受孕。故而我们在临床常见备孕半年以内未受孕，而前来就诊者，说明患者对孕育的关注程度，远高于月经不调对患者造成的影响。3.证型分布以肾虚血瘀、肾虚肝郁、气滞血瘀为主。通过研究显示中医对卵巢储备功能下降的基本病因归为“肾虚、血瘀、肝郁”，本研究通过对卵巢储备功能下降患者主诉、中医诊断及辨证情况进行分析统计，月经改变是巢储备功能下降最首要的外在表现，从而可知“月经后期”、“月经过少”是卵巢储备功能下降的两个典型症状，临床常同时并存，逐渐发展，最后可致闭经。鉴于目前尚无判断卵巢储备功能下降的诊断金标准，现有的诊断标准无法明确其程度与分期，故此次研究只是小样本的临床探讨，只能说明部分卵巢储备功能下降患者的特征，不能整个囊括月经紊乱的规律，还待大样本临床探讨。
（二）补肾活血方干预肾虚血瘀型卵巢储备功能下降之月经后期、过少的临床研究结果：补肾活血方对卵巢储备功能下降之月经后期、过少患者的临床症状有明显的改善作用，中药组总有效率及显效率与西药组相比无显著差异（P>0.05）。说明在治疗DOR的临床疗效上，补肾活血方与西药克龄蒙功效相当。在治疗过程中中药组有2人不孕症患者妊娠，多次体外受精-胚胎移植失败的1人成功助孕，由此可知补肾活血方（法）在治疗不孕症方面占据优势。在改善DOR患者中医证候上，中药组、西药组均取得非常好的疗效（p＜0.01）。两组间比较，补肾活血方比克龄蒙效果更佳（p＜0.01），说明在改善DOR患者证候上，中西医均有效，且中药组效果更显著。停药3个月后，中药组、西药组治疗前后有显著性差异，而空白组与上述两组治疗后比较有显著性差异，说明药物可以改善卵巢储备功能下降患者的症状，并且中药组短期综合疗效明显。中药组治疗前后各项症状积分相比，均有非常显著性差异（p＜0.01），表明了补肾活血方可以明显改善DOR患者的各项临床症状，体现了补肾活血方的补肾、养血、活血功效。西药组治疗前后各项症状积分相比，在改善月经延后、色暗有块、潮热汗出、性欲减退方面，有非常显著性差异（p＜0.01），说明克龄蒙可以改善DOR患者月经量少及雌激素下降引起的类绝经期症状；却不能改善腰骶酸痛、头晕耳鸣等症状（p＞0.05）。中药组在改善DOR患者腰骶酸软、头晕耳鸣等肾虚方面疗效更佳卓著，体现补肾活血方的补肾功效；在改善月经量少、色暗有块方面有显著性差异（p＜0.05），提示中药与西药相比在改善DOR患者经量、经质时效果明显，可能系中药组活血、养血药物调节脏腑功能之体现；在改善月经延后、潮热汗出、性欲减退方面无显著性差异（p＞0.05）。经Ridit分析（以两组合并作为标准组），中药组患者调经疗效优于西药组。补肾活血方对性激素水平有一定的调节作用，补肾活血方、克龄蒙均可明显改善DOR患者的激素水平。在LH方面有显著性差异（P<0.05），而其他方面无显著性差异，说明激素水平调节方面，中药组与西药组大致相当，仅仅在LH方面略显优势。治疗后中药组、西药组分别与3个月后空白组FSH、LH、FSH/LH、E2比较，均有非常显著性差异（P<0.01）。中西药均可以上调卵巢颗粒细胞抑制素B蛋白、抗苗勒氏管激素(AMH)的表达，改善卵巢储备功能（P<0.01）。阴式B超检查中AFC、PSV、PI、RI方面有非常显著性差异（P<0.05），补肾活血方在增加窦卵泡数、改善卵巢血供（PSV、PI、RI）上效果优于西药组。以上说明补肾活血方对卵巢储备功能下降具有良好的临床疗效，并且它的短期综合疗效明显优于西药组，短期综合疗效较稳定。
结论：①通过小样本卵巢储备功能下降患者的中医证候分布研究显示卵巢储备功能下降患者的中医证型以肾虚血瘀、肾虚肝郁居多，月经改变是巢储备功能下降最首要的外在表现，“月经后期”、“月经过少”是卵巢储备功能下降的两个典型症状。另一方面，“月经后期”、“月经过少”作为中医治疗月经病的难点问题之一，如何通过中医药治疗，改善月经量、调整月经周期，是本研究的主要目的。②补肾活血方干预肾虚血瘀型DOR之月经后期、过少的效应机理可能通过干预调节生殖激素、抑制卵巢颗粒细胞凋亡、促进卵巢血管生成而实现。③肾虚血瘀型DOR的主要临床症状为月经延后，月经量少，色暗有块，小腹痛，块下痛减，腰骶酸痛、头晕耳鸣、潮热汗出、性欲减退。舌淡或紫暗边有瘀斑，脉沉细或沉涩。④补肾活血方干预肾虚血瘀型DOR之月经后期、过少的短期疗效明显优于单纯西药治疗，合理运用补肾活血方干预DOR，疗效显著，对预防、延缓POF的发生具有非常积极的意义，从而可以提高女性生活质量。⑤基础血FSH、LH、FSH/LH、E2、INHB和AMH及经阴道B超检查中的卵巢体积、AFC、PSV、PI、RI可作为临床诊断、评估DOR的可靠辅助检查指标。⑥依据中医“治未病”的理论，在卵巢功能储备功能下降的疾病发展过程中，DOR可认为是POF的“未病”阶段，POF是“已病”阶段。所以通过临床症状及实验室检查尽早发现DOR，运用“治未病”的观点指导我们在整个治疗过程中的遣方用药，积极干预，中断发展趋势。
PURPOSE: The ovarian reserve function (Ovarian Reservation， OR)refers to the ability of ovarian cortex follicle growth anddevelopment， forming a fertilized follicles. Therefore，reproductive function recession is the quality and quantity of theoocyte cortex follicles stored down，this is the diminished ovarianreserve (Decreasing Ovarian Reservation， DOR) of the basicconnotation of. In recent years， with the development of society，culture， living environment， work pressure and other changes，the incidence of DOR increased year by year， seriously affectingwomen's reproductive health and quality of life. But the existingdomestic universities and medical textbook are not poor ovarianreserve function disorder of the devoted， The content ofoccasionally in amenorrhea，infertility，menopause syndrome，therelevant literature is also very little，clinical treatment pathlack systematic， comprehensive theoretical explanation andsignificance，the specification. Therefore， we according tosyndrome differentiation and treatment，on the basis of the clinicalcurative effect of TCM basic theory. Using the idea and method of modern scientific explanating effect mechanism of BushenhuoxueFang treatment of kidney deficiency and blood ovarian reservedecline in the late menstruation. To investigate the clinicaltreatment of tonifying the kidney and promoting blood circulationand effective intervention of kidney deficiency and blood stasistype of diminished ovarian reserve，to provide scientific basis forthe traditional Chinese medicine is effective in the treatment ofdiminished ovarian reserve.
METHODS：Research on intervention mechanism of previous singlemedicine Astragalus on anovulatory rats showed astragalus rootobviously curative effect for female ovulation, endocrine therapy.In this study, following the first advantage and compositionconsists of astragalus root and dodder Bushen Huoxue Fang once againconducted clinical and theoretical research: This text is dividedinto three parts. The first part“Study of traditional literaturediminished ovarian reserve”，According to reading books classics,combined with modern clinical and experimental research, thecurrent research situation and development of traditional Chinesemedicine and Western Medicine on ovarian reserve function. Thesecond part“Study on the distribution of TCM Syndromes of DOR”，According to the analysis of the traditional Chinese medicinedisease belong todisease differentiation criteria of traditionalChinese medicine, according toTCM differentiation standard tojudge its TCM syndrome types, analysis to explore thecharacteristics of TCM Syndromes. The third part “the ClinicalResearch of Bushenhuoxue Fang in Treating Kidney Deficiency andBlood Stasis Menopathy result from declining ovarian reserve”，study Validity of Bushenhuoxue Fang in Treating Kidney Deficiency and Blood Stasis Menopathy result from declining ovarian reserve，Observation of DOR patients by Bushenhuoxue Fang before and afterthe treatment， the symptoms and signs of integral，to study Changeof the level changes of blood basis of FSH， LH， FSH/LH and E2，INHB， AMH，AFC，the volume of ovary，PSV，RI，PI，Etc.
RESULTS:The first part：The decline of ovarian reserve functionof distribution of TCM Syndromes of survey results:①Research showsthat the symptoms of patients with infertility rate, menstruation,menstrual cycle after the fault.②The Chinese medicine diagnosis,menstruation, menstruation, infertility. The symptoms sort,"infertility" ranking in the first place, and in the diagnosis ofTCM sort,"infertility" ranking in third. Investigate its reason,considered as related to mental patients. Think in more patients,menstruation or menstrual period, do not affect normal life, andbe of no importance, not cause obvious discomfort, so its discomfortis not sufficient attention. Since thousands of years Chinese on"people" attention, resulting in women is extremely sensitive tothe "birth". Some patients think, once begin to prepare forpregnancy; it should be a short time insemination. Therefore wecommon pregnant within six months of non pregnancy in clinical, andcame to visit, the patient attention to inoculation, far higher thanthe irregular menstruation effect on patients caused by.③Syndromedistribution to kidney deficiency and blood stasis, kidneydeficiency and liver qi stagnation, Qi and blood stasis. Throughthe research shows the basic cause Chinese descent on ovarianreserve function as "kidney deficiency, blood stasis, stagnationof liver qi", menstrual change is the nest functional reserveexternal performance the most important, is directly reflect the decline in female fertility, through the study on the ovarianreserve function decline, the patient complained of TCM diagnosisand syndrome differentiation were analyzed statistically, thus the"late period","menstruation" is the decline of ovarian reservefunction of two typical symptoms, clinical often coexist at the sametime, develop gradually, and finally can cause amenorrhea. In viewof the fact that there is no judgment the diagnostic gold standarddiminished ovarian reserve, the existing diagnostic criteria cannot clear the extent and staging, this study is the small sampleclinical study, can only explain part of the diminished ovarianreserve patient characteristics, not the whole encompassingmenstrual disorder rules, also be big sample clinical study.Thesecond part：Results of the clinical research of bushenhuoxue fangin treating kidney deficiency and blood stasis menopathy resultfrom declining ovarian reserve：①The clinical symptoms of "BushenHuoxue Fang on menstrual ovarian function decline, too late"patients have obvious improvement, traditional Chinese medicinegroup total effective rate and significant efficiency and thewestern medicine group showed no significant difference (P>0.05).The clinical efficacy in the treatment of DOR, effect of BushenHuoxue Decoction and Western medicine Climen effect is equivalentto. In the course of treatment of traditional Chinese medicine group,pregnancy2infertility patients,1person times of in vitrofertilization and embryo transfer failure success helps is pregnant,so the Bushen Huoxue Fang (Law) occupy the advantage in thetreatment of infertility.②In improving the TCM syndrome inpatients with DOR syndrome, traditional Chinese medicine group,western medicine group has very good curative effect (P<0.01). The comparison between two groups, better than the effect of BushenHuoxue Climen (P<0.01), in the patients with DOR syndrome,traditional Chinese medicine and Western medicine are effective,and the traditional Chinese medicine group has more remarkableeffect.3months after drug withdrawal, there was significantdifference before and after the Chinese medicine group, westernmedicine treatment group and blank group, and the two groups aftertreatment were significant difference, the medicine can improve thesymptoms of patients with diminished ovarian reserve, and thetherapeutic effect of traditional Chinese medicine group was short.③Compared with the Chinese medicine group before and aftertreatment the symptom integral, there was significant difference(P<0.01), show that the effect of Bushen Huoxue Decoction cansignificantly improve the clinical symptoms of the patients withDOR, the effect of Bushen Huoxue Decoction of invigorating thekidney, nourishing the blood, promoting blood circulation effect.Compared with the western medicine group before and after treatmentthe symptom integral, in the improvement of delayed menstruation,color block, hectic fever and sweating, hyposexuality, there wasa significant difference (P<0.01), explain Climen can improvepatients with DOR menstruation and menopause syndrome caused bydecreased estrogen class like; but does not improve the lumbosacralpain, dizziness tinnitus symptoms (P>0.05). Traditional Chinesemedicine group in improving DOR in patients with lumbosacral achingand limp, dizziness and tinnitus, kidney deficiency on bettercurative effect, embodies the Bushen Huoxue Fang kidney; inimproving menstrual quantity is little, there is a dark color withsignificant difference (P<0.05), suggesting that traditional Chinese medicine and Western medicine in patients with DOR comparedto the volume, the matter, obviously, traditional Chinese medicinegroup and activating blood, nourishing the blood may reflect theinternal organs function of drug regulation; there was nosignificant difference in the improvement of delayed menstruation,hectic fever and sweating, hyposexuality aspects (P>0.05).④By theanalysis of Ridit (the two together as the standard group), Chinesemedicine group is better than western medicine group menstruation.⑤Effect of Bushen Huoxue decoction has certain effect onregulating the levels of sex hormones, Bushen Huoxue Fang, Climencould significantly improve the hormone levels in patients with DOR.There were significant differences in LH (P<0.05), but nosignificant difference in other aspects, the hormone levelregulation, traditional Chinese medicine group and Westernmedicine group is roughly equal, only slightly in the LH advantage.After the treatment of traditional Chinese medicine group andWestern medicine group, respectively, and3months after the blankgroup FSH, LH, FSH/LH, E2, there was significant difference(P<0.01).⑥Chinese and Western medicine could increase ovariangranulosa cell inhibin B protein, anti Mullerian hormone (AMH)expression, improve the ovarian reserve function (P<0.01).⑦Therewas a significant difference between female B ultrasoundexamination in AFC, PSV, PI, RI (P<0.05), Bushen Huoxue Fang on theincreasing number of antral follicles, improve the ovarian bloodsupply (PSV, PI, RI) is better than western medicine group. Theeffect of Bushen Huoxue decoction has good curative effect onovarian reserve function decline, and short-term therapeuticeffect of it is better than medicine group, short-term curative effect is stable.
CONCLUSION：①Through a small sample of diminished ovarian reservedistribution of TCM Syndromes of patients showed a decline inovarian reserve function of TCM syndromes in patients with kidneydeficiency and blood stasis, kidney deficiency and liver stagnationin multiple, menstrual change is the nest functional reserveexternal performance the most important,"late period","menstruation" is the decline of ovarian reserve function twotypical symptoms. On the other hand,"late period","menstruation"as the Chinese medicine treatment of menstrual disease one of themost difficult issues, how to improve the treatment of traditionalChinese medicine, menstrual quantity, adjust the menstrual cycle,is the main purpose of this study.②Effects and mechanism of BushenHuoxue Fang intervention menstrual blood stasis DOR, too late mayinterfere with the regulation of reproductive hormones, inhibit theapoptosis of ovarian granulosa cells of ovary, promote angiogenesisand implementation.③The main clinical symptoms of kidneydeficiency and blood stasis type DOR for delayed menstruation,menstrual quantity is little, there is a dark color, small abdominalpain, block alleviation of pain, lumbosacral pain, dizziness andtinnitus, hectic fever and sweating, sexual hypoesthesia. Paletongue or dark purple edge petechiae, pulse small or astringent.④Short term effect of Bushen Huoxue Fang intervention menstrualblood stasis DOR, too late is better than pure western medicinetreatment, rational use of Bushen Huoxue Fang intervention DOR,obvious curative effect, to prevent the occurrence of POF, delayis a very positive meaning, which can improve the quality of lifeof women.⑤Based on FSH, LH, FSH/LH, blood E2, INHB and AMH and transvaginal B ultrasound examination of the ovarian volume, AFC,PSV, PI, RI can be used as a reliable auxiliary examination indexof clinical diagnosis, assessment of DOR.⑥According totraditional Chinese medicine "preventive treatment of disease"theory, course of the disease decline in ovarian reserve function,DOR can be considered to be POF "no disease" stage, POF is "disease"stage. So based on the clinical symptoms and laboratory examinationto find DOR, the use of "preventive treatment of disease" point ofview to guide us in the whole course of treatment of the prescription,active intervention, interrupt the development trend.
引文
[1]Moinpour CM，Feigl P，Match B，et al. Quality of life end pointsin cancer clinical trials: review and recommendations [J]. JNatl Cancer Inst，1989，81(7):485-495.
[2]金红花，夏阳.益精补冲汤治疗卵巢储备功能低下55例临床观察[J].中医杂志，2008，48(9):790-792.
[3]Welt CK. Primary ovarian insufficiency: a more accurate term forpremature ovarian failure [J].Clin En DORrinol (Oxf)，2008，68(4)：499-509.
[4]Nelson LM. Primary ovarian insufficiency[J].N Engl J Med，2009，360(6):606-614.
[5]韩玉芬，程淑蕊，敬文娜，等.卵巢储备功能下降的预测及治疗[J].中国计划生育学杂志，2007，15（2）:117.
[6]Soules MR，Sherman S，Parrott E，et al. Executive summary：Stagesof Reproductive Aging Workshop（STRAW）.Fertil Steril，2001，76（5）：874.
[7]许小风，范春.卵巢早衰与卵巢储备功能下降的相关发病因素探讨[J]，中国循证医学杂志，20l1，11(4)：400-403.
[8]李玉艳，梁志清.子宫内膜异位症手术治疗对生育功能的影响.实用妇产科杂志，2008，24（10）：579.
[9]Laissue P，Lakhal B，Benayoun BA，et al. Functional evidenceimplicating FOXL2in non-syndromic premature ovarian failureand in the regulation of the transcription factor OSR2.J MedGenet，2009，46（7）：455.
[10]Laissue P，Vinci G，Veitia RA，et al. Recent advances in thestudy of genes involved in non-syndromic premature ovarianfailure. Mol Cell Endocrinol，2008，282（1-2）：101.
[11]Kok HS，van Asselt KM，van der Schouw YT，et al. Genetic studiesto identify genes underlying menopausal age. Hum Reprod Update，2005，11（5）：483.
[12]Skillern A，Rajkovic A. Recent developments in identifyinggenetic determinants of premature ovarian failure. Sex Dev，2008，2（4-5）：228.
[13]BancsiLF，Broekmans FJ，Eijkmans MJ，et a1.Predictors of poorovarian response in vitrofertilization：a prospective studycomparing basal markes of ovarian reserve.Fertil Steril，2002，77(2)：328-336.
[14]Zaidi J，BraberJ，Kyei-Mensah A，et a1.Relationship of ovarianstromal blood flow at the baseline ultrasound scan to subsequentfollicular response in an in vitro fertilization program [J].Obstet Gynecol，1996，88(5)：779-784.
[15]Kim SH，Ku SY，Jee BC，et a1.Links Clinical significance oftransvaginal color Doppler ultrasonography of the ovarianartery as a predictor of ovarian response in controlled ovarianhyperstimulation for in vitro fertilization and embryotransfer[J]. J Assist ReProd Genet，2002，19(3)：lO3-112.
[16]王伟群，张华，蔡款，等.经阴道彩色多普勒超声检查对卵巢储备功能下降患者卵巢基础状态的评价[J/CD].中华医学超声杂志:电子版，2011，8(7):1543-1548.
[17]Knauff EA， Franke L，van Es MA，et al. Genome–wide associationstudy in premature ovarian failure patients suggests ADAMTS19as a possible candidate gene. Hum Reprod，2009，24（9）：2372
[18]Rebar RW. Premature ovarian “failure” in the adolescent. AnnNY Acad Sci，2008，1135：138.
[19]许小凤，谈勇，陈宣伊.卵巢储备功能下降中医证治思路和优势.中国中医药信息杂志，2009，16（12）：88.
[20]尹巧芝，谷红苹，刘奕.浅析中医治未病思想对防治卵巢储备功能下降的指导作用.陕西中医学院学报，2010，33（4）：14.
[21]崔晓萍，陈蕊，张勤，等.循期阴阳序贯疗法改善卵巢早衰前期卵巢储备功能的临床研究思路探讨.陕西中医，2010，31（2）：198.
[22]Rabinovlci J， Jaffe RB， Development and regulation of growthand differentiated funtion of human and subhuman primate fetalgonads. Endocr Rev，1990，（11）:532.
[23]Baker TG.A quantitative and cyto10gical study of germ cells inhuman ovaries. Proc Roy Soc Lond，1963;158:417.
[24]Gondos B， Bhiraleus P， Hobel C.Ultrastructural observationson germ cells in human fetal ovaries. Am J Obstet Gynecol，1986;155:189.
[25]Ennis S， Ward D， Murray A.Nonlinear association between CGGrepeat number and age of menopause in FMRI premutation carriers[J].Eur J Hum Genet，2006，14(2):253-255.
[26]Rao L， Babu A， Padmalatha V，et al.Novel X-chromosomal defectassociated with abnormal ovaian function[J].J Obstet GynaecolRes，2005，31(1):12-15.
[27]Rao L，Baub A，Padmalatha V，et al.Novel X chromosomal defectassociated with abnormal ovarian function[J].J Obstet GynaecolRes，2005，31(1):12-15.
[28]韩玉芬，程淑蕊，敬文娜，等.卵巢储备功能下降的预测及治疗[J]中国计划生育学杂志，2007，136(2):117.
[29]杨业洲，韩字研.卵巢早衰的防治原则[J].实用妇产科杂志.2003，19（4）：202.
[30]李淑萍.滋肾疏肝法治疗卵巢储备功能下降35例疗效观察[J].四川中医，2004，22（12）：62.
[31]丁淑瑾.卵巢早衰的病因与治疗[J].海南医学，2008，19(1)：125-126.15.
[32]卢洁，施艳秋.诱发卵巢早衰的相关性因素[J].临床医药实践杂志，2008，17(10).
[33]陈兰，曹佩霞.FOXL2评估卵巢储备功能的临床应用[J].湖北民族学院学报，2010，27(1)：75-77.
[34]谢梅青.卵巢早衰的病因[J].实用妇产科杂志，2003，19(4)：193-194.
[35]Steiner AZ， Baird DD， Kesner JS. Mother's menopausal age isassociated with her daughter's early follicular phase urinaryfolliclestimulating hormone level [J]. Menopause，2008，15(5):940-944.
[36]Bretherick RL， Fluker MR， Robinson WP. X repeat sizes in thegray zone and high end of the normal range aye associated withpremature ovarian failure [J]. HunGenet，2005，117(4):376-382.
[37]Denburg RA， Van Dooren MF， de Graaf B，et al. A genome widelinkage scan in a Dutch family identifies premature ovarianfailure susceptibility [J]. Hum Reprod.2008，23(12)：2835-2841.
[38]金婧.卵巢早衰的病因研究进展[J].实用妇产科杂志，2007，23(3)：142-145.
[39]F. J. Broekmans， M. R. Soules， B. C. Fauser. Ovarian Aging:Mechanisms and Clinical Consequences [J]. Endocrine Reviews，August2009，30(5):465-493.
[40]Laissue P， Lakhal B， Benayoun BA， et al. Functional evidenceimplicating FOXL2in non-syndromic premature ovarian failureand in the regulation of the transcription factor OSR2[J].MedGenet，2009，46(7):455-457.
[41]Gebbie AE.Premature ovarian failure. Menopause Int.2008，Sep，14(3):96.
[42]王一峰，欧汝强，杨宁，等.卵巢早衰患者血清抗透明带抗体和肿瘤坏死因子-α、γ-干扰素及白细胞介素-2的分析[J].生殖医学杂志，2002，11（1）:7-10.
[43]ChattoPadhyay D，Sen MR，Chat EN， et aI. Antiovarian antibodyin Premature ovarian failure [J].Indian J Med Sci，1999，53(6):254-258.
[44]Russell P.The clinicpatho10gical premature ovarian failure [J].Verh D tsch Ges Patho1，1997，81(6):197-200.
[45]Goswami D， Conway GS. Premature ovarian failure [J]. HormRes.2007，68(4):196-202.
[46]马小红.卵巢早衰与自身免疫机制的研究进展[J].中国计划生育学杂志，2007，3(137)：186-188.
[47]Menezo YJ， Lescaille M， Nicollet B， et al， Pregnancy anddelivery after stimulation with rFSH of a galatosemia patientsuffering hpergaonadotropie hypogonadism: case report [J]. JAssist Repord Genet，2004，21(3):89-90.
[48]郑敏，冯云.卵巢早衰的病因[J].国外医学妇产科学分册，2005，32（3）：164-167.
[49]Hock DL， Sharafi K， Dagostino L， et al. Contribution ofdiminished ovarian reserve to hypofertility associated withendometriosis[J]. J Reprod Med，2001，46(1):7-10.
[50]Kuivasaari P， Hippelainen M， Anttila M，et al. Effect ofendometriosis on IVF/ICSI outcome: stage III/IV endometriosisworsens cumulative epregnancy and live-born rates[J]. HumReprod，2005，20(11):3130-3135.
[51]许晓燕，徐克惠.达那唑对卵巢功能安全性的基础研究[J].西部医学，2009，21(5):722-724.
[52]Minton E， Munster N. Chemotherapy-induced arnenorrhea andfertility in women undergoing adjuvant treatment for breastcancer [J].Cancer Control，2002，9(6):466-472.
[53]Yang BH，Parkin DM，Cai L.Cancer burden and trends in the AsianPacific Rim region[J]. Asian Pac J Cancer Prev，2004，5(2):96-111.
[54]谢梅青.卵巢早衰的病因[J].实用妇产科杂志，2003，19(4):193-195.
[55]Roman H， Sentilhes L， Cingotti M， et al. Uterinedevaseularization and subsequent major intrauterine synechiaeand ovgrian failure[J]. Fertil Steril，2005，83(3):755-757.
[56]Ryu PKCH， Chrisman HB， Omary RA， et al. The vascular impactof uterineartery embollzation prospective sonographicassessment of ovarian arterial circulation [J].Vasc IntervRadiol，2001，12(9):1071.
[57]刘媛媛.妇科手术对卵巢功能的影响[J].广西医学，2011，33(12)：1638-1641.
[58]Laissue P， Lakhal B， Benayoun BA， et al. Functional evidenceimplicating FOXL2in non-syndromic premature ovarian failureand in the regulation of the transcription factor OSR2[J].MedGenet，2009，46(7):455-457.
[59]Hviid A， Rubin S， MUhlemann K.Mumps [J].Lance，2008，37(1):932-944.
[60]Matikainen T， Perez GI， Jurisicova A， et aI. Aro-maticHydrocarbon receptor-driven Bax gene ex-pression is requiredfor premature ovarian failure caused by biohazardousenvironmental chemical [J].Nat Genet，2001，28(4):355-360.
[61]Luborsky JK，Meyer P， Sowers MF，et al.Premature menopause ina mult-ethnic population study ofthe menopause transition[J].Hum Reprod，2003，18(10):199-206.
[62]Zaidi S，Usmani A， Shokh IS，et al.Ovarian reserve and BMIbetween fertile and subfertile women[J].J Coll Physicians SurgPak，2009，19(1):21-24.
[63]Abdalla H， Thum MY. An elevated basal FSH reflects aquantitative rather than qualitative decline of the ovarianreverse [J]. Hum Reprod，2004，19(4):893-898.
[64]Taraeiuk MB， Nolting M， Femandez G， et al. Psycho10gicalassessment of patients with premature ovarian failure [J].Gynecol Endoerinol，2008，24(1):45-53.
[65]Hendrick V， Giflin M， Ahshuler L， et al. Antidepressantmedications， mood and male fertility [J]. Psychoneuroen-docrinology，2000，25(1):37-51.
[66]马丽灵，阮祥燕.100例卵巢早衰相关因素的调查分析[J].实用妇产科杂志，2009，25（4）:212-215.
[67]陈静，阮祥燕.65例育龄妇女卵巢储备功能下降的临床研究分析[J].医学综述，2011，17(8):1253-1255.
[68]许小风，范春.卵巢早衰与卵巢储备功能下降的相关发病因素探讨[J]，中国循证医学杂志，20l1，11(4)：400-403.
[69]Pal L， BevilacquaK， Santoro NF. Chronicles psychosocialstressors are detrimental to ovarian reserve: a study ofinfertile women [J]. J Psychosom Obstet Gynaecol，2010，31(3):130-139.
[70]徐彩，金哲，林晓华，等.慢性精神应激对雌性大鼠卵巢储备功能的影响研究[J].疑难病杂志，2013，(2).124-126+167.
[71]Blanck HM， Marcus M， Tolbert PE， et al. Time to menopausein relation to PBBs， PCBs and smoking [J]. Maturitas，2004，49(2):97-106.
[72]Matikaimen T， Pere GI， Jurisicova A， et al. Aromatichydrocarbon receptor driven Bax gene expression esrequrred forpremature ovarian failure caused by biohazar dens enviromnentalchemicals [J].Nat Gene，2001，28(4):355-360.
[73]Harkness LS， Bonny AE.Calcium and vitamin D status in theadolescent: key roles for bone，body weight，glucose tolerance，and estrogen biosynthesis [J].J Pediatr Adolesc Gynecol，2005，18(5):305-311.
[74]陈静，阮祥燕.65例育龄妇女卵巢储备功能下降的临床研究分析[J].医学综述，2011，17（8）:1253-1255.
[75]Testa G， Chiaffarino F， Vegelti W， et al.Case-control studyon risk factors for premature ovarian failure [J]. GynecolObstet Invest，2001，51(1):40-43.
[76]蒋利华，姚珍薇，张新华，等.卵巢早衰危险因素的病例对照研究[J].重庆医科大学学报2006，31(3)：424-426，445.
[77]Laissue P， Vinci G， Veitia RA， et al. Recent advances in thestudy of genes involved in non-syndromic premature ovarianfailure [J].Mol Cell Endocrinol，2007，8（2）：19-24.
[78]Chuang CC， Chen CD， Chao KH， et al. Age is a better predictorof pregnancy potential than basal follicle-stimulating hormonelevels in women undergoing in vitro fertilization [J]. FertilSteril，2003，79(1):63-68.
[79]Tarek EI-Toukhy， Yacoub Khalaf， Roger Hart， et al. Young agedoes not protect against the adverse effects of reduced ovarianreserve-an eight year study [J]. Human Reproduction，2002，17(6):1519-1524.
[80]林仙华，叶碧绿，赵军招，等.基础FSH/LH比值对预测年轻不孕患者IVF-ET周期卵巢反应性的影响［J］.现代妇产科进展，2006，15（12）：930-933.
[81]H.Abdalla， M.Y.Thum. An elevated basal FSH reflects aquantitative rather than qualitative decline of the ovarianreserve [J]. Human Reproduction，2004，19(4):893-898.
[82]Lass A， Gerrard A， Abusheikha N， et al. IVF performance ofwomen who have fluctuating early follicular FSH levels [J]. JAssist Reprod Genet，2000，17(10):566-573.
[83]Hiroshi TYN. Value of FSH determination on day of the IVF cycleinduced by GnRHa suppression for prediction of ovarian response[J]. Fertil Steril，1999，44(4):9-13.
[84]Frattarelli JI， Bergh PA， Drews MR，et a1.Evaluation of basalestradiol levels in assisted reproductive techno10gy cycles [J].Fertil Steri1，2000，74(3):518-524.
[85]A Shrim， SE Elizur， DS Seidman， et a1.Elevated day3FSH/LHratio due to low LH concentrations predicts reduced ovarianresponse [J]. Reproductive BioMedicine Online，2006，12(4):418-422.
[86]A Shrim， SE Elizur， DS Seidman， et al. Elevated day3FSH/LHratio due to low LH concentrations predicts reduced ovarianresponse [J]. Reproductive BioMedicine Online，2006，12(4):418-422.
[87]Schild RL， Knobloch C， Dorn C， et al. The role of ovarianvolume in an in vitro fertilization programme as assessed by3Dultrasound [J]. Arch Gynecol Obstet，2001，265(2):67.
[88]E.R.Klinkert，F.J.M.Broekmans，C.W.N.Looman，et al. Expectedpoor responders on the basis of an antral follicle count do notbenefit from a higher starting dose of gonadotrophins in IVFtreatment: a randomized controlled trial [J]. HumanReproduction，2005，20(3):611-615.
[89]B.Popovic-Todorovic， A.Loft， A.Lindhard， et al. Aprospective study of predictive factors of ovarian response in‘standard’ IVF/ICSI patients treated with recombinant FSH. Asuggestion for a recombinant FSH dosage normogram [J]. HumanReproduction，2003，18(4):781-787.
[90]T am SL， Zaidi J， Campbell S， et al. Blood flowchanges inovarian and uterine arteries during the normal menstrual cycle[J]. Am J Obstet Gynecol，1996，175(31):625-627.
[91]Kupesic S， Kurjak A. Predictors of IVF outcome bythree-dimensional ultrasound [J]. Human Reproduction，2002，17(4):950-955.
[92]B.Popovic-Todorovic， A.Loft， A.Lindhard， et al. Aprospective study of predictive factors of ovarian response in‘standard’ IVF/ICSI patients treated with recombinant FSH. Asuggestion for a recombinant FSH dosage normogram [J]. HumanReproduction，2003，18(4):781-787.
[93]Navot D， Rosenwaks X， Marqalioth EJ. Prognostic assessmentof female fecundity [J].1987，2(60):645-647.
[94]Kahraman S， Vicdan K， Isik AZ， et al. Clomiphene citratechallenge test in the assessment of ovarian reserve beforecontrolled ovarian hyperstimulation for intracytoplasmic sperminjection [J]. Eur J Obstet Gynecol Reprod Biol，1997，73(2):177-182.
[95]Vladimirov IK，Tacheva DM，Kalinov KB，et al. Prognostic valueof some ovarian reserve tests in poor responders [J]. ArchGynecol Obstet，2005，272(1):74-79.
[96]Iwase A， Ando H， Kuno K， et al. Use of follicle-stimulatinghormone test to predict poor response in in vitro fertilization[J]. The American College of Obstetricians and Gyneco10gists，2005，105(3):645-652.
[97]Shrim A，Elizur SE，Seidman DS，et al.Elevated day3FSH/LHratiodue to low LH concentrations predicts reduced ovarianresponse.Repred Biomed Online，2006，12(4)：418-422.
[98]Ranieri DM， Phophong P， Khadum I， et al. Simultaneousevaluation of basal FSH and oestradiol response to GnRH ana10gueallows effective drug regimen selection for IVF [J]. HumanReproduction，2001，16(4):673-675.
[99]Fawzy M， Lambert A， Harrison RF， et al. Day5inhibin B levelsin a treatment cycle are predictive of IVF outcome [J]. HumReprod，2002，17(6):1535-1543.
[100]吴日然，廖月婵，叶云，等.测定血清抑制素B水平预测卵巢储备力及调节控制性超排卵用药的研究[J].中华妇产科杂志，2005，40(10):679-681.
[101]Creus M，Penarrubia J，Fabregues F，et al. Day3serum inhibinB and FSH and age as predictors of assisted reproductiontreatment outcome [J]. Hum Reprod，2000，5(11):2341-2346.
[102]I.A.J.van Rooij，F.J.M.Broekmans，E.R.te Velde，et al. Serumanti-Mullerian hormone levels: a novel measure of ovarianreserve [J]. Human Reproduction，2002，17(12):3065-3071.
[103]Tremellen KP， Kolo M， Gilmore A， et al. Anti-Müllerianhormone as a marker of ovarian reserve [J]. Australian and NewZealand Journal of Obstetrics and Gynaeco10gy，2005，45(1):20-24.
[104]Joana Penarrubia， Francisco Fabregues， Dolors Manau. Basaland stimulation day5anti-Mu llerian hormone serumconcentrations as predictors of ovarian response and pregnancyin assisted reproductive techno10gy cycles stimulated withgonadotropin-releasing hormone agonist-gonadotropin treatment[J]. Human Reproduction，2005，20(4):915-922.
[105]Tilly，Kowalski KI，Johnson AL，et al.Involvement of apoptosisin Ovarian follicular atresia and postovulatory regression [J].Endocrino10gy，1991，129(5)：2799-2801.
[106]Bagavant H，Fusi FM，Baiseh J，et al.Immunogenieity andeontraeeptive Potential of a humanzona Pellueida3PePtidevaeeine [J].BiodReprod，1997，56(2):764-770.
[107]王素荣，李辉杰.人工周期治疗60例卵巢储备功能低下的体会[J]，现代医药卫生，2011，27(4):566-567.
[108]谢美群，赵蔚.28例卵巢储备功能低下不孕症的治疗体会[J].浙江实用医学，2006，11(5):346-347.
[109]Rees MC. Premature menopause: Hormone replacement therapy isindeed indicated [M]，2008，336(7654):1148.
[110]林守清.激素补充治疗临床应用指南[J].实用妇产科杂志2004，20(3):136.
[111]Rehar RW. Premature ovarian “failure”in the adolescent [J].Ann NY Acad Sci，2008，225(1135):138.
[112]Kronenberg HM，Melmed S，Polonsky KS，et al. Williams Text bookof Endocrino10gy [M].11thed. Philadelphia: W B SaundersCompany，2008,11(8):683.
[113]Cleicher N， Barad DH， Dehydroepiandrosterone (DHEA)supplementation in diminished ovarian reserve (DOR)[J].ReprodBiol Endocrinol，2011，6(9):67.
[114]Norbert Gleicher，Eddy Ryan et al. Miscarriage rates afterdehydroepiandrosterone (DHEA) supplementation in women withdiminished ovarian reserve: a case control study [J].Reproductive Bio10gy and Endocrino10gy，2009，7:108.
[115]Norbert Gleicher， Andrea Weghofer， et al.Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy:direct evidence from preimplantation genetic screening (PGS)[J]. Reproductive Bio10gy and Endocrin10gy.2010，8(10):140.
[116]Kayhan Yakin，Bulent Urman. DHEA as a miracle drug in thetreatment of poor: esponders; hype or hope?[J].HumanReproduction，2011，26(8):1941-1944.
[117]B Corenblum， T Rowe， and PJ Tay lo. rHihg dose， short–temrgluococr tiocidsofrthe treatment of infertility resultingfrom Premature ovariana filure [J]. FertiISetriL，1993，59(5):988-91.
[118]Crha I， Hruba D， Ventruba P， et al. Ascorbic acid and infertility treatment [J].Cent Eur J Public Health，2003，11(2):63.
[119]Lam IT， Schulz-Lobmery I， Obruca A，et aI. Premature ovarianfailure: etioiogy and prospects [J]. Gynecol Endocrin0l，2000;14(7):1777.
[120]张玉珍.新世纪全国高等中医药院校规划教材中医妇科学[M].北京：中国中医药出版社，2002：17.
[121]孙园园，许小凤.许小凤治疗卵巢储备功能下降经验[J].江西中医药，2013，44（7）:15-16.
[122]美克热阿依迪力夏提.齐聪教授治疗卵巢储备功能低下的经验总结[J].四川中医，2013，36(2):19-21.
[123]蔡光霞，田维萍，何雨聪，吴克明.吴克明教授治疗卵巢储备功能下降经验撷箐[J].世界中西医结合杂志，2013，8（7）:664-665，678.
[124]陈赟，钱菁，夏桂成.夏桂成教授辨治卵巢功能低下性不孕症经验探析[J].北京中医药大学学报，2013，36(2):129-131.
[125]廉印玲.郭志强教授治疗卵巢储备功能下降引起闭经的经验[J].内蒙古中医药，2011，15(12):147.
[126]梁风香.论中医调治心脾防治POF[J].北京中医药，2009，28(12)：945-947.
[127]朱玲，罗颂平.卵巢早衰的病因病机及其证治[J]，中医药学刊，2003，21(1):143-144.
[128]杨冬梅，陆东权，景致英.温阳疏肝法治疗卵巢储备功能下降不孕症56例临床观察[J].四川中医，2013，31(5)，103-105.
[129]朱玲，罗颂平.卵巢早衰的病因病机及其证治[J].中医药学刊，2003，21(1):143-144.
[130]余丽梅，陈爱妮，陈慧侬.自拟滋阴清热育卵方治疗卵巢储备功能下降44例[J].广西中医药，2013，36（2），25-26.
[131]刘小古.加减知柏地黄汤治疗阴虚火旺型卵巢储备功能低下的临床研究[D].导师：周惠芳.:南京中医药大学，2013.
[132]尹巧芝，谷红苹，等，浅析中医治未病思想对防治卵巢储备功能下降的指导作用[J].陕西中医学院学报，2010，33(4):14-15.
[133]姚石安.卵巢早衰中西医证治需注意哪些方面[J].中医杂志，1998，39(5):313.
[134]蔡光霞，田维萍，何雨聪，等.吴克明教授治疗卵巢储备功能下降经验撷箐[J].世界中西医结合杂志，2013，8(7).265-267.
[135]蔡光霞，田维萍，何雨聪，等.吴克明教授治疗卵巢储备功能下降经验撷箐[J].世界中西医结合杂志，2013，8(7).664-665+668.
[136]孙园园，许小凤.许小凤治疗卵巢储备功能下降经验[J].江西中医药，2013，44(7).15-16.
[137]李玲，金哲，黄文玲，等.乌萸汤含药血清对大鼠卵巢颗粒细胞INHB、FSHRmRNA及分泌功能的影响[J].天津中医药，2010，28(2).144-146.
[138]付媛，曹保利，孟庆芳.中药周期疗法治疗对卵巢储备功能的影响
[C].2010全国中西医结合围绝经期专题学术会议论文集.2010：66-69.
[139]黄欲晓，蔡连香，李亚俐.中药内服外用法对卵巢储备功能影响的临床研究[J].中国实验方剂学杂志，2008，14(10).66-67.
[140]张迎春，李芳园，李兰荣，等.针药对卵巢储备功能影响的临床研究[J].四川中医，2010，28(12):103-104.
[141]何玉琼，梁雪雯，苏建芬，等.情志护理配合中医治疗卵巢早衰[J].护士进修杂志，2006，21(12)：1137-1138.
[142]何淑明，梁丽霞，黄惠芳，等.仿生物电刺激治疗卵巢储备功能下降患者的疗效[J].广东医学，2013，34(12）：1851-1855.
[143]冯晓军，孙伟，王力，等.电针联合盆底肌按摩治疗卵巢早衰疗效观察[J].山东中医药大学学报，2011，35(1).43-44.
[144]窦晓青.女性压力性尿失禁的诊断与治疗—女性盆底解剖结构[J].山东医药，2006，46(24):89.
[145]来玉芹，韦立红，郭钦源，等.中药联合埋线治疗卵巢储备功能下降7例[J].河北中医，2012，34(4).523-524.
[146]徐恒泽.针灸学[M].北京:人民卫生出版社，2002:462-463.
[147]张玉珍.中医妇科学[M].新世纪第2版，北京：中国中医药出版社，2007，4(8):79-80，94-95.
[148]郑筱萸主编.中药新药临床研究指导原则[M].北京：中国医药科技出版社，2002:240-241.
[149]张正红，杨留才.不孕妇女心理因素、家庭因素和社会支持研究及护理对策[J].实用临床医药杂志，2011，15(22):185-187.
[150]黄红玉，陈建红.不孕妇女社会心理的调查分析[J].湘南学院学报(自然科学版)，2004，6(4):47-48.
[151]陈淑颖.不孕不育患者社会心理特点及其影响[J].生殖与避孕.2003，23(6):351-354.
[152]胡军，曹杰，李国荣，等.不育妇女心理因素的相关性研究[J].职业与健康，2002，18(9):79-81.
[153]李淑萍.滋肾疏肝法治疗卵巢储备功能下降35例疗效观察[J].四川中医，2004，22(12):62-63.
[154]严讳，何月萍.卵巢储备功能下降的中医证治思路和优势[J].第十次全国中医妇科学术大会论文集，2010:89-91.
[155]陈春晓.卵巢储备功能下降中医证候特征及内分泌特征的研究[D].导师：朱玲.广州中医药大学，2010:25-36.
[156]郑筱萸.中药新药临床研究指导原则[M].北京：中国医药科技出版社，2002，4:2.
[157]余凌，李惊子，王海燕.黄芪当归在肾脏疾病中的应用及其机制研究进展[J].中国中西医结合杂志，2001，21(5):396.
[158]王建红，王敏璋，伍庆华.菟丝子黄酮对应激大鼠卵巢内分泌的影响[J].中草药，2002，33(12)：1099-1101.
[159]崔瑛，颜正华，侯士良，等，论熟地黄的益智作用与研究思路[J].中国中药杂，2002，27(6)：404-406.
[160]倪艳.山茱萸的研究进展.中药研究通讯，1990，(总34):70.
[161]山原条二.现代东洋医学[M]，1986，(3):51-53
[162]臧莲碧，郑怡健.山茱萸抗衰老实验研究.浙江中医学院学报[J]，1993，17(5):34.
[163]项平.七种中药抗老作用的实验观察[J]，辽宁:中医杂志，1982，24（3）:44.
[164]王淑兰，李淑莲，董祟田，等.枸杞子等八种中药提取液对体外培养细胞和小鼠腹腔巨噬细胞影响的实验研究[J].白求恩医科大学学报，1990,16(4)：325-328.
[165]杨铁虹，贾敏，梅其炳.当归多糖对小鼠免疫功能的调节作用[J].中成药，2005，27(5)：563-565.
[166]韩涛，王宝恩，马学梅.复方中药对肝星状细胞胶原合成与降解的影响[J].天津医药，2001，29(11):671-673.
[167]李秋怡，干国平，刘炎文.川芎的化学成分及药理研究进展[J].时珍国医国药，2006，17（7）：1298-1299.
[168]金若敏，陈兆善，陈长勋，等.益母草治疗痛经机制探索[J].中国现代应用药学，2004，21(2)90-93.
[169]王立，张国斌段妍君，等.益母草胶囊抗炎镇痛作用的研究[J].湖北中医杂志，2005，27(8)53-54.
[170]丁伯平，熊莺，徐朝阳，等.益母草碱对急性血瘀证大鼠血液流变学的影响[J].中国中医药科技，2004，11(1)36-37.
[171]丁伯平，熊莺，徐朝阳，等.益母草注射液对失血性休克大鼠淋巴微循环的作用[J].陕西医药，2004，25(8)759.
[172]曹玫，张洪，张晓燕，等.香附的药理活性作用研究进展[J].药物流行病学杂志，2010，19(2)：111-113.
[173]Bernard L，Andre T， Irene Z，et al.Administration of Cyperusrotundas Tubers Extract prevents Weight Gain in Obese Zuckerrats [J].Phytother Res，2007，21（8）:724-730.
[174]Soumaya K，Mohamed BS，I lef L，et al.In vitro evaluation ofantibacterial，antioxidant，cytotoxic and apoptotic activitiesof the tubers infusion and extracts of Cyperus otundus [J].Bioresource Techno10gy，2008，99（18）:9004-9008.
[175]张发初，张耀德，刘绍光.香附子之药理研究第一次报告：南京市香附子流浸膏对于子宫之作用[C].药理研究报告，1985,5(2)：148.
[176]奚明.促黄体汤对假孕大鼠卵巢轴功能影响仁[J].中西医结合杂志，1992，12(8):476.
[177]蔡春环.高促性腺激素闭经22例分析[J].中原医刊，2002，(6)29：35-36.
[178]程湘，陈止琼，谢荣凯，等.盐酸氟两汀联合雌激素治疗绝经期抑郁症的临床观察[J].重庆医学，2005，34(5):721～722，724.
[179]卢莉，李建平，薛云珍，等.情绪反应、个性特征与月经失调的关系[J].中国心理卫生杂志，2005，19(3):156～158.
[180]孙玉芳，余立群，褚芳.长期心理应激对卵巢功能影响的实验研究[J].实验动物利学，2009，26(3）:27～28.
[181]罗仁.肾虚证流行病学调查报告[J].第一军医大学学报，1992，1(4)：357.
[182]林守清.激素补充治疗临床应用指南[J].实用妇产科杂志，2004，20(3):136-137.
[183]李力，薛晓琳，徐雯洁，等.“治未病”思想在亚健康防治中的意义[J].健康教育，2008，27(1)：76-77.
[184]冯文林，吴弥漫.《内经》“治未病”治则的思想探源[J].中国中医基础医学杂志，2006，12(12)：886-887.
[185]刘进，李国信，李丹.治未病学术思想探源及研究展望[J].中华中医药学刊，2008，6(26)：1309-1312.
[186]金光亮.《内经》未病概念与“治未病”理论探讨[J].北京中医药大学学报，2006，29(12)：804-806.
[187]许小凤，谈勇.卵巢储备功能低下中医证治路径探析[J].环球中医药，2010，3(5):325-327.
[188]韩兰香，杜娟，郭杨志等.丛慧芳辨治卵巢早衰治疗经验[J].四川中医，2012，30(2):16-17.
[189]金红花.益精补冲汤治疗卵巢储备功能低下55例临床观察[J].中医杂志，2008，49(9)：790.
[190]韩玉芬，程淑蕊，敬文娜，等.卵巢储备功能下降的预测及治疗[J].中国计划生育学杂志，2007，15(2):117.
[191]杨冬梓，杨炜敏.卵巢储备功能的检测方法[J].实用妇产科杂，2003，4(19):196.
[192]蔡连香，周佩云.从“治未病"角度探讨防治卵巢储备功能下降和卵巢早衰[J].浙江中医药大学学报，2009，33(5):713-714.
[193]谢京红，姜坤.中医治疗卵巢储备功能低下性月经不调临床观察[J].世界中医药，2008，3(6):338-339.
[194]张道云.肝郁气滞导致卵巢功能减退的理论探讨[J].中国中医药信息杂志，2005，12(10):92.
[195]王针织，俞超序.补肾化瘀祛痰方对雄激素致不孕大鼠卵巢局部调控因子的影响[J].中西医结合学报，2008，6(4):361-365.
[196]邓颖.自拟补肾调冲汤治疗高原地区卵巢早衰200例临床观察[J].四川中医，2009，27(5):92-93.
[197]韩连玉，叶亚智.抗卵衰冲剂治疗卵巢早衰36例临床研究[J].辽宁中医杂志，2008，35（3）：404.
[198]池雷，夏桂成.夏桂成教授调周疗法治疗月经病述要[J].实用医技杂志，2008，15（33）：4914.
[199]李晓燕.中药人工周期疗法治疗卵巢功能低下所致不孕症[J].辽宁中医学院学报，2002，4(2):133.
[200]郭金，张英杰，谭方信.益肾汤对初老雌性大鼠卵巢颗粒细胞超微结构的影响[J].成都中医药大学学报，2008，30(4):448-451.
[201]李淑萍，李玲.补肾调冲法治疗卵巢功能失调性不孕的实验研究[J].中国中医药信息杂志，2002，3(9):33-34.
[202]蔡立荣，李大金，孙晓溪.补肾活血方对小鼠实验性卵巢早衰防治作用的研究[J].中国中西医结合杂志，2001，2(21):126-129.
[203]朱玲，罗颂平，许丽绵.左归丸对免疫性卵巢早衰小鼠抗卵巢抗体的影响[J].现代中西医结合杂志，2006，25(4):435-438.
[204]朱玲，罗颂平，许丽绵.左归丸对小鼠自身免疫性卵巢损伤的保护作用[J].中国中两医结合杂志，2005，10(25):920-924.
[205]黄菊，罗丽莉，傅玉才，等.淫羊藿试对大鼠早期卵巢卵泡发育和卵母细胞凋亡影响的初步研究[J].中国现代医学杂志，2007，17(5):523-527.
[206]王翠霞，陈莹.补肾复方对初老大鼠卵巢颗粒细胞凋亡相关蛋白Bcl-2/Bax表达的影响[J].中医药学刊，2005，8(23):1402-1403.
[207]李军，王翠霞，陈莹.补肾复方延缓雌性大鼠卵巢早衰的实验研究[J].辽宁中医杂志2007，5(3):681-683.
[208]沙桂娥，赵文民.针灸治疗卵巢早衰34例临床观察[J].中国针灸1999，19(4):199-201.
[209]陈瑞雪，李艳红，马晓晶等.电针治疗卵巢早衰的疗效观察[J].中国中医基础医学杂志，2009，15(3):208.
[210]周佩云，黄欲哓，吴五香.蔡连香教授采用中药内服外用治疗POF经验[J].中华中医药杂志，2010，25(10):1613-1615.
[2]金红花，夏阳.益精补冲汤治疗卵巢储备功能低下55例临床观察[J].中医杂志，2008，48(9):790-792.
[3]Welt CK. Primary ovarian insufficiency: a more accurate term forpremature ovarian failure [J].Clin En DORrinol (Oxf)，2008，68(4)：499-509.
[4]Nelson LM. Primary ovarian insufficiency[J].N Engl J Med，2009，360(6):606-614.
[5]韩玉芬，程淑蕊，敬文娜，等.卵巢储备功能下降的预测及治疗[J].中国计划生育学杂志，2007，15（2）:117.
[6]Soules MR，Sherman S，Parrott E，et al. Executive summary：Stagesof Reproductive Aging Workshop（STRAW）.Fertil Steril，2001，76（5）：874.
[7]许小风，范春.卵巢早衰与卵巢储备功能下降的相关发病因素探讨[J]，中国循证医学杂志，20l1，11(4)：400-403.
[8]李玉艳，梁志清.子宫内膜异位症手术治疗对生育功能的影响.实用妇产科杂志，2008，24（10）：579.
[9]Laissue P，Lakhal B，Benayoun BA，et al. Functional evidenceimplicating FOXL2in non-syndromic premature ovarian failureand in the regulation of the transcription factor OSR2.J MedGenet，2009，46（7）：455.
[10]Laissue P，Vinci G，Veitia RA，et al. Recent advances in thestudy of genes involved in non-syndromic premature ovarianfailure. Mol Cell Endocrinol，2008，282（1-2）：101.
[11]Kok HS，van Asselt KM，van der Schouw YT，et al. Genetic studiesto identify genes underlying menopausal age. Hum Reprod Update，2005，11（5）：483.
[12]Skillern A，Rajkovic A. Recent developments in identifyinggenetic determinants of premature ovarian failure. Sex Dev，2008，2（4-5）：228.
[13]BancsiLF，Broekmans FJ，Eijkmans MJ，et a1.Predictors of poorovarian response in vitrofertilization：a prospective studycomparing basal markes of ovarian reserve.Fertil Steril，2002，77(2)：328-336.
[14]Zaidi J，BraberJ，Kyei-Mensah A，et a1.Relationship of ovarianstromal blood flow at the baseline ultrasound scan to subsequentfollicular response in an in vitro fertilization program [J].Obstet Gynecol，1996，88(5)：779-784.
[15]Kim SH，Ku SY，Jee BC，et a1.Links Clinical significance oftransvaginal color Doppler ultrasonography of the ovarianartery as a predictor of ovarian response in controlled ovarianhyperstimulation for in vitro fertilization and embryotransfer[J]. J Assist ReProd Genet，2002，19(3)：lO3-112.
[16]王伟群，张华，蔡款，等.经阴道彩色多普勒超声检查对卵巢储备功能下降患者卵巢基础状态的评价[J/CD].中华医学超声杂志:电子版，2011，8(7):1543-1548.
[17]Knauff EA， Franke L，van Es MA，et al. Genome–wide associationstudy in premature ovarian failure patients suggests ADAMTS19as a possible candidate gene. Hum Reprod，2009，24（9）：2372
[18]Rebar RW. Premature ovarian “failure” in the adolescent. AnnNY Acad Sci，2008，1135：138.
[19]许小凤，谈勇，陈宣伊.卵巢储备功能下降中医证治思路和优势.中国中医药信息杂志，2009，16（12）：88.
[20]尹巧芝，谷红苹，刘奕.浅析中医治未病思想对防治卵巢储备功能下降的指导作用.陕西中医学院学报，2010，33（4）：14.
[21]崔晓萍，陈蕊，张勤，等.循期阴阳序贯疗法改善卵巢早衰前期卵巢储备功能的临床研究思路探讨.陕西中医，2010，31（2）：198.
[22]Rabinovlci J， Jaffe RB， Development and regulation of growthand differentiated funtion of human and subhuman primate fetalgonads. Endocr Rev，1990，（11）:532.
[23]Baker TG.A quantitative and cyto10gical study of germ cells inhuman ovaries. Proc Roy Soc Lond，1963;158:417.
[24]Gondos B， Bhiraleus P， Hobel C.Ultrastructural observationson germ cells in human fetal ovaries. Am J Obstet Gynecol，1986;155:189.
[25]Ennis S， Ward D， Murray A.Nonlinear association between CGGrepeat number and age of menopause in FMRI premutation carriers[J].Eur J Hum Genet，2006，14(2):253-255.
[26]Rao L， Babu A， Padmalatha V，et al.Novel X-chromosomal defectassociated with abnormal ovaian function[J].J Obstet GynaecolRes，2005，31(1):12-15.
[27]Rao L，Baub A，Padmalatha V，et al.Novel X chromosomal defectassociated with abnormal ovarian function[J].J Obstet GynaecolRes，2005，31(1):12-15.
[28]韩玉芬，程淑蕊，敬文娜，等.卵巢储备功能下降的预测及治疗[J]中国计划生育学杂志，2007，136(2):117.
[29]杨业洲，韩字研.卵巢早衰的防治原则[J].实用妇产科杂志.2003，19（4）：202.
[30]李淑萍.滋肾疏肝法治疗卵巢储备功能下降35例疗效观察[J].四川中医，2004，22（12）：62.
[31]丁淑瑾.卵巢早衰的病因与治疗[J].海南医学，2008，19(1)：125-126.15.
[32]卢洁，施艳秋.诱发卵巢早衰的相关性因素[J].临床医药实践杂志，2008，17(10).
[33]陈兰，曹佩霞.FOXL2评估卵巢储备功能的临床应用[J].湖北民族学院学报，2010，27(1)：75-77.
[34]谢梅青.卵巢早衰的病因[J].实用妇产科杂志，2003，19(4)：193-194.
[35]Steiner AZ， Baird DD， Kesner JS. Mother's menopausal age isassociated with her daughter's early follicular phase urinaryfolliclestimulating hormone level [J]. Menopause，2008，15(5):940-944.
[36]Bretherick RL， Fluker MR， Robinson WP. X repeat sizes in thegray zone and high end of the normal range aye associated withpremature ovarian failure [J]. HunGenet，2005，117(4):376-382.
[37]Denburg RA， Van Dooren MF， de Graaf B，et al. A genome widelinkage scan in a Dutch family identifies premature ovarianfailure susceptibility [J]. Hum Reprod.2008，23(12)：2835-2841.
[38]金婧.卵巢早衰的病因研究进展[J].实用妇产科杂志，2007，23(3)：142-145.
[39]F. J. Broekmans， M. R. Soules， B. C. Fauser. Ovarian Aging:Mechanisms and Clinical Consequences [J]. Endocrine Reviews，August2009，30(5):465-493.
[40]Laissue P， Lakhal B， Benayoun BA， et al. Functional evidenceimplicating FOXL2in non-syndromic premature ovarian failureand in the regulation of the transcription factor OSR2[J].MedGenet，2009，46(7):455-457.
[41]Gebbie AE.Premature ovarian failure. Menopause Int.2008，Sep，14(3):96.
[42]王一峰，欧汝强，杨宁，等.卵巢早衰患者血清抗透明带抗体和肿瘤坏死因子-α、γ-干扰素及白细胞介素-2的分析[J].生殖医学杂志，2002，11（1）:7-10.
[43]ChattoPadhyay D，Sen MR，Chat EN， et aI. Antiovarian antibodyin Premature ovarian failure [J].Indian J Med Sci，1999，53(6):254-258.
[44]Russell P.The clinicpatho10gical premature ovarian failure [J].Verh D tsch Ges Patho1，1997，81(6):197-200.
[45]Goswami D， Conway GS. Premature ovarian failure [J]. HormRes.2007，68(4):196-202.
[46]马小红.卵巢早衰与自身免疫机制的研究进展[J].中国计划生育学杂志，2007，3(137)：186-188.
[47]Menezo YJ， Lescaille M， Nicollet B， et al， Pregnancy anddelivery after stimulation with rFSH of a galatosemia patientsuffering hpergaonadotropie hypogonadism: case report [J]. JAssist Repord Genet，2004，21(3):89-90.
[48]郑敏，冯云.卵巢早衰的病因[J].国外医学妇产科学分册，2005，32（3）：164-167.
[49]Hock DL， Sharafi K， Dagostino L， et al. Contribution ofdiminished ovarian reserve to hypofertility associated withendometriosis[J]. J Reprod Med，2001，46(1):7-10.
[50]Kuivasaari P， Hippelainen M， Anttila M，et al. Effect ofendometriosis on IVF/ICSI outcome: stage III/IV endometriosisworsens cumulative epregnancy and live-born rates[J]. HumReprod，2005，20(11):3130-3135.
[51]许晓燕，徐克惠.达那唑对卵巢功能安全性的基础研究[J].西部医学，2009，21(5):722-724.
[52]Minton E， Munster N. Chemotherapy-induced arnenorrhea andfertility in women undergoing adjuvant treatment for breastcancer [J].Cancer Control，2002，9(6):466-472.
[53]Yang BH，Parkin DM，Cai L.Cancer burden and trends in the AsianPacific Rim region[J]. Asian Pac J Cancer Prev，2004，5(2):96-111.
[54]谢梅青.卵巢早衰的病因[J].实用妇产科杂志，2003，19(4):193-195.
[55]Roman H， Sentilhes L， Cingotti M， et al. Uterinedevaseularization and subsequent major intrauterine synechiaeand ovgrian failure[J]. Fertil Steril，2005，83(3):755-757.
[56]Ryu PKCH， Chrisman HB， Omary RA， et al. The vascular impactof uterineartery embollzation prospective sonographicassessment of ovarian arterial circulation [J].Vasc IntervRadiol，2001，12(9):1071.
[57]刘媛媛.妇科手术对卵巢功能的影响[J].广西医学，2011，33(12)：1638-1641.
[58]Laissue P， Lakhal B， Benayoun BA， et al. Functional evidenceimplicating FOXL2in non-syndromic premature ovarian failureand in the regulation of the transcription factor OSR2[J].MedGenet，2009，46(7):455-457.
[59]Hviid A， Rubin S， MUhlemann K.Mumps [J].Lance，2008，37(1):932-944.
[60]Matikainen T， Perez GI， Jurisicova A， et aI. Aro-maticHydrocarbon receptor-driven Bax gene ex-pression is requiredfor premature ovarian failure caused by biohazardousenvironmental chemical [J].Nat Genet，2001，28(4):355-360.
[61]Luborsky JK，Meyer P， Sowers MF，et al.Premature menopause ina mult-ethnic population study ofthe menopause transition[J].Hum Reprod，2003，18(10):199-206.
[62]Zaidi S，Usmani A， Shokh IS，et al.Ovarian reserve and BMIbetween fertile and subfertile women[J].J Coll Physicians SurgPak，2009，19(1):21-24.
[63]Abdalla H， Thum MY. An elevated basal FSH reflects aquantitative rather than qualitative decline of the ovarianreverse [J]. Hum Reprod，2004，19(4):893-898.
[64]Taraeiuk MB， Nolting M， Femandez G， et al. Psycho10gicalassessment of patients with premature ovarian failure [J].Gynecol Endoerinol，2008，24(1):45-53.
[65]Hendrick V， Giflin M， Ahshuler L， et al. Antidepressantmedications， mood and male fertility [J]. Psychoneuroen-docrinology，2000，25(1):37-51.
[66]马丽灵，阮祥燕.100例卵巢早衰相关因素的调查分析[J].实用妇产科杂志，2009，25（4）:212-215.
[67]陈静，阮祥燕.65例育龄妇女卵巢储备功能下降的临床研究分析[J].医学综述，2011，17(8):1253-1255.
[68]许小风，范春.卵巢早衰与卵巢储备功能下降的相关发病因素探讨[J]，中国循证医学杂志，20l1，11(4)：400-403.
[69]Pal L， BevilacquaK， Santoro NF. Chronicles psychosocialstressors are detrimental to ovarian reserve: a study ofinfertile women [J]. J Psychosom Obstet Gynaecol，2010，31(3):130-139.
[70]徐彩，金哲，林晓华，等.慢性精神应激对雌性大鼠卵巢储备功能的影响研究[J].疑难病杂志，2013，(2).124-126+167.
[71]Blanck HM， Marcus M， Tolbert PE， et al. Time to menopausein relation to PBBs， PCBs and smoking [J]. Maturitas，2004，49(2):97-106.
[72]Matikaimen T， Pere GI， Jurisicova A， et al. Aromatichydrocarbon receptor driven Bax gene expression esrequrred forpremature ovarian failure caused by biohazar dens enviromnentalchemicals [J].Nat Gene，2001，28(4):355-360.
[73]Harkness LS， Bonny AE.Calcium and vitamin D status in theadolescent: key roles for bone，body weight，glucose tolerance，and estrogen biosynthesis [J].J Pediatr Adolesc Gynecol，2005，18(5):305-311.
[74]陈静，阮祥燕.65例育龄妇女卵巢储备功能下降的临床研究分析[J].医学综述，2011，17（8）:1253-1255.
[75]Testa G， Chiaffarino F， Vegelti W， et al.Case-control studyon risk factors for premature ovarian failure [J]. GynecolObstet Invest，2001，51(1):40-43.
[76]蒋利华，姚珍薇，张新华，等.卵巢早衰危险因素的病例对照研究[J].重庆医科大学学报2006，31(3)：424-426，445.
[77]Laissue P， Vinci G， Veitia RA， et al. Recent advances in thestudy of genes involved in non-syndromic premature ovarianfailure [J].Mol Cell Endocrinol，2007，8（2）：19-24.
[78]Chuang CC， Chen CD， Chao KH， et al. Age is a better predictorof pregnancy potential than basal follicle-stimulating hormonelevels in women undergoing in vitro fertilization [J]. FertilSteril，2003，79(1):63-68.
[79]Tarek EI-Toukhy， Yacoub Khalaf， Roger Hart， et al. Young agedoes not protect against the adverse effects of reduced ovarianreserve-an eight year study [J]. Human Reproduction，2002，17(6):1519-1524.
[80]林仙华，叶碧绿，赵军招，等.基础FSH/LH比值对预测年轻不孕患者IVF-ET周期卵巢反应性的影响［J］.现代妇产科进展，2006，15（12）：930-933.
[81]H.Abdalla， M.Y.Thum. An elevated basal FSH reflects aquantitative rather than qualitative decline of the ovarianreserve [J]. Human Reproduction，2004，19(4):893-898.
[82]Lass A， Gerrard A， Abusheikha N， et al. IVF performance ofwomen who have fluctuating early follicular FSH levels [J]. JAssist Reprod Genet，2000，17(10):566-573.
[83]Hiroshi TYN. Value of FSH determination on day of the IVF cycleinduced by GnRHa suppression for prediction of ovarian response[J]. Fertil Steril，1999，44(4):9-13.
[84]Frattarelli JI， Bergh PA， Drews MR，et a1.Evaluation of basalestradiol levels in assisted reproductive techno10gy cycles [J].Fertil Steri1，2000，74(3):518-524.
[85]A Shrim， SE Elizur， DS Seidman， et a1.Elevated day3FSH/LHratio due to low LH concentrations predicts reduced ovarianresponse [J]. Reproductive BioMedicine Online，2006，12(4):418-422.
[86]A Shrim， SE Elizur， DS Seidman， et al. Elevated day3FSH/LHratio due to low LH concentrations predicts reduced ovarianresponse [J]. Reproductive BioMedicine Online，2006，12(4):418-422.
[87]Schild RL， Knobloch C， Dorn C， et al. The role of ovarianvolume in an in vitro fertilization programme as assessed by3Dultrasound [J]. Arch Gynecol Obstet，2001，265(2):67.
[88]E.R.Klinkert，F.J.M.Broekmans，C.W.N.Looman，et al. Expectedpoor responders on the basis of an antral follicle count do notbenefit from a higher starting dose of gonadotrophins in IVFtreatment: a randomized controlled trial [J]. HumanReproduction，2005，20(3):611-615.
[89]B.Popovic-Todorovic， A.Loft， A.Lindhard， et al. Aprospective study of predictive factors of ovarian response in‘standard’ IVF/ICSI patients treated with recombinant FSH. Asuggestion for a recombinant FSH dosage normogram [J]. HumanReproduction，2003，18(4):781-787.
[90]T am SL， Zaidi J， Campbell S， et al. Blood flowchanges inovarian and uterine arteries during the normal menstrual cycle[J]. Am J Obstet Gynecol，1996，175(31):625-627.
[91]Kupesic S， Kurjak A. Predictors of IVF outcome bythree-dimensional ultrasound [J]. Human Reproduction，2002，17(4):950-955.
[92]B.Popovic-Todorovic， A.Loft， A.Lindhard， et al. Aprospective study of predictive factors of ovarian response in‘standard’ IVF/ICSI patients treated with recombinant FSH. Asuggestion for a recombinant FSH dosage normogram [J]. HumanReproduction，2003，18(4):781-787.
[93]Navot D， Rosenwaks X， Marqalioth EJ. Prognostic assessmentof female fecundity [J].1987，2(60):645-647.
[94]Kahraman S， Vicdan K， Isik AZ， et al. Clomiphene citratechallenge test in the assessment of ovarian reserve beforecontrolled ovarian hyperstimulation for intracytoplasmic sperminjection [J]. Eur J Obstet Gynecol Reprod Biol，1997，73(2):177-182.
[95]Vladimirov IK，Tacheva DM，Kalinov KB，et al. Prognostic valueof some ovarian reserve tests in poor responders [J]. ArchGynecol Obstet，2005，272(1):74-79.
[96]Iwase A， Ando H， Kuno K， et al. Use of follicle-stimulatinghormone test to predict poor response in in vitro fertilization[J]. The American College of Obstetricians and Gyneco10gists，2005，105(3):645-652.
[97]Shrim A，Elizur SE，Seidman DS，et al.Elevated day3FSH/LHratiodue to low LH concentrations predicts reduced ovarianresponse.Repred Biomed Online，2006，12(4)：418-422.
[98]Ranieri DM， Phophong P， Khadum I， et al. Simultaneousevaluation of basal FSH and oestradiol response to GnRH ana10gueallows effective drug regimen selection for IVF [J]. HumanReproduction，2001，16(4):673-675.
[99]Fawzy M， Lambert A， Harrison RF， et al. Day5inhibin B levelsin a treatment cycle are predictive of IVF outcome [J]. HumReprod，2002，17(6):1535-1543.
[100]吴日然，廖月婵，叶云，等.测定血清抑制素B水平预测卵巢储备力及调节控制性超排卵用药的研究[J].中华妇产科杂志，2005，40(10):679-681.
[101]Creus M，Penarrubia J，Fabregues F，et al. Day3serum inhibinB and FSH and age as predictors of assisted reproductiontreatment outcome [J]. Hum Reprod，2000，5(11):2341-2346.
[102]I.A.J.van Rooij，F.J.M.Broekmans，E.R.te Velde，et al. Serumanti-Mullerian hormone levels: a novel measure of ovarianreserve [J]. Human Reproduction，2002，17(12):3065-3071.
[103]Tremellen KP， Kolo M， Gilmore A， et al. Anti-Müllerianhormone as a marker of ovarian reserve [J]. Australian and NewZealand Journal of Obstetrics and Gynaeco10gy，2005，45(1):20-24.
[104]Joana Penarrubia， Francisco Fabregues， Dolors Manau. Basaland stimulation day5anti-Mu llerian hormone serumconcentrations as predictors of ovarian response and pregnancyin assisted reproductive techno10gy cycles stimulated withgonadotropin-releasing hormone agonist-gonadotropin treatment[J]. Human Reproduction，2005，20(4):915-922.
[105]Tilly，Kowalski KI，Johnson AL，et al.Involvement of apoptosisin Ovarian follicular atresia and postovulatory regression [J].Endocrino10gy，1991，129(5)：2799-2801.
[106]Bagavant H，Fusi FM，Baiseh J，et al.Immunogenieity andeontraeeptive Potential of a humanzona Pellueida3PePtidevaeeine [J].BiodReprod，1997，56(2):764-770.
[107]王素荣，李辉杰.人工周期治疗60例卵巢储备功能低下的体会[J]，现代医药卫生，2011，27(4):566-567.
[108]谢美群，赵蔚.28例卵巢储备功能低下不孕症的治疗体会[J].浙江实用医学，2006，11(5):346-347.
[109]Rees MC. Premature menopause: Hormone replacement therapy isindeed indicated [M]，2008，336(7654):1148.
[110]林守清.激素补充治疗临床应用指南[J].实用妇产科杂志2004，20(3):136.
[111]Rehar RW. Premature ovarian “failure”in the adolescent [J].Ann NY Acad Sci，2008，225(1135):138.
[112]Kronenberg HM，Melmed S，Polonsky KS，et al. Williams Text bookof Endocrino10gy [M].11thed. Philadelphia: W B SaundersCompany，2008,11(8):683.
[113]Cleicher N， Barad DH， Dehydroepiandrosterone (DHEA)supplementation in diminished ovarian reserve (DOR)[J].ReprodBiol Endocrinol，2011，6(9):67.
[114]Norbert Gleicher，Eddy Ryan et al. Miscarriage rates afterdehydroepiandrosterone (DHEA) supplementation in women withdiminished ovarian reserve: a case control study [J].Reproductive Bio10gy and Endocrino10gy，2009，7:108.
[115]Norbert Gleicher， Andrea Weghofer， et al.Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy:direct evidence from preimplantation genetic screening (PGS)[J]. Reproductive Bio10gy and Endocrin10gy.2010，8(10):140.
[116]Kayhan Yakin，Bulent Urman. DHEA as a miracle drug in thetreatment of poor: esponders; hype or hope?[J].HumanReproduction，2011，26(8):1941-1944.
[117]B Corenblum， T Rowe， and PJ Tay lo. rHihg dose， short–temrgluococr tiocidsofrthe treatment of infertility resultingfrom Premature ovariana filure [J]. FertiISetriL，1993，59(5):988-91.
[118]Crha I， Hruba D， Ventruba P， et al. Ascorbic acid and infertility treatment [J].Cent Eur J Public Health，2003，11(2):63.
[119]Lam IT， Schulz-Lobmery I， Obruca A，et aI. Premature ovarianfailure: etioiogy and prospects [J]. Gynecol Endocrin0l，2000;14(7):1777.
[120]张玉珍.新世纪全国高等中医药院校规划教材中医妇科学[M].北京：中国中医药出版社，2002：17.
[121]孙园园，许小凤.许小凤治疗卵巢储备功能下降经验[J].江西中医药，2013，44（7）:15-16.
[122]美克热阿依迪力夏提.齐聪教授治疗卵巢储备功能低下的经验总结[J].四川中医，2013，36(2):19-21.
[123]蔡光霞，田维萍，何雨聪，吴克明.吴克明教授治疗卵巢储备功能下降经验撷箐[J].世界中西医结合杂志，2013，8（7）:664-665，678.
[124]陈赟，钱菁，夏桂成.夏桂成教授辨治卵巢功能低下性不孕症经验探析[J].北京中医药大学学报，2013，36(2):129-131.
[125]廉印玲.郭志强教授治疗卵巢储备功能下降引起闭经的经验[J].内蒙古中医药，2011，15(12):147.
[126]梁风香.论中医调治心脾防治POF[J].北京中医药，2009，28(12)：945-947.
[127]朱玲，罗颂平.卵巢早衰的病因病机及其证治[J]，中医药学刊，2003，21(1):143-144.
[128]杨冬梅，陆东权，景致英.温阳疏肝法治疗卵巢储备功能下降不孕症56例临床观察[J].四川中医，2013，31(5)，103-105.
[129]朱玲，罗颂平.卵巢早衰的病因病机及其证治[J].中医药学刊，2003，21(1):143-144.
[130]余丽梅，陈爱妮，陈慧侬.自拟滋阴清热育卵方治疗卵巢储备功能下降44例[J].广西中医药，2013，36（2），25-26.
[131]刘小古.加减知柏地黄汤治疗阴虚火旺型卵巢储备功能低下的临床研究[D].导师：周惠芳.:南京中医药大学，2013.
[132]尹巧芝，谷红苹，等，浅析中医治未病思想对防治卵巢储备功能下降的指导作用[J].陕西中医学院学报，2010，33(4):14-15.
[133]姚石安.卵巢早衰中西医证治需注意哪些方面[J].中医杂志，1998，39(5):313.
[134]蔡光霞，田维萍，何雨聪，等.吴克明教授治疗卵巢储备功能下降经验撷箐[J].世界中西医结合杂志，2013，8(7).265-267.
[135]蔡光霞，田维萍，何雨聪，等.吴克明教授治疗卵巢储备功能下降经验撷箐[J].世界中西医结合杂志，2013，8(7).664-665+668.
[136]孙园园，许小凤.许小凤治疗卵巢储备功能下降经验[J].江西中医药，2013，44(7).15-16.
[137]李玲，金哲，黄文玲，等.乌萸汤含药血清对大鼠卵巢颗粒细胞INHB、FSHRmRNA及分泌功能的影响[J].天津中医药，2010，28(2).144-146.
[138]付媛，曹保利，孟庆芳.中药周期疗法治疗对卵巢储备功能的影响
[C].2010全国中西医结合围绝经期专题学术会议论文集.2010：66-69.
[139]黄欲晓，蔡连香，李亚俐.中药内服外用法对卵巢储备功能影响的临床研究[J].中国实验方剂学杂志，2008，14(10).66-67.
[140]张迎春，李芳园，李兰荣，等.针药对卵巢储备功能影响的临床研究[J].四川中医，2010，28(12):103-104.
[141]何玉琼，梁雪雯，苏建芬，等.情志护理配合中医治疗卵巢早衰[J].护士进修杂志，2006，21(12)：1137-1138.
[142]何淑明，梁丽霞，黄惠芳，等.仿生物电刺激治疗卵巢储备功能下降患者的疗效[J].广东医学，2013，34(12）：1851-1855.
[143]冯晓军，孙伟，王力，等.电针联合盆底肌按摩治疗卵巢早衰疗效观察[J].山东中医药大学学报，2011，35(1).43-44.
[144]窦晓青.女性压力性尿失禁的诊断与治疗—女性盆底解剖结构[J].山东医药，2006，46(24):89.
[145]来玉芹，韦立红，郭钦源，等.中药联合埋线治疗卵巢储备功能下降7例[J].河北中医，2012，34(4).523-524.
[146]徐恒泽.针灸学[M].北京:人民卫生出版社，2002:462-463.
[147]张玉珍.中医妇科学[M].新世纪第2版，北京：中国中医药出版社，2007，4(8):79-80，94-95.
[148]郑筱萸主编.中药新药临床研究指导原则[M].北京：中国医药科技出版社，2002:240-241.
[149]张正红，杨留才.不孕妇女心理因素、家庭因素和社会支持研究及护理对策[J].实用临床医药杂志，2011，15(22):185-187.
[150]黄红玉，陈建红.不孕妇女社会心理的调查分析[J].湘南学院学报(自然科学版)，2004，6(4):47-48.
[151]陈淑颖.不孕不育患者社会心理特点及其影响[J].生殖与避孕.2003，23(6):351-354.
[152]胡军，曹杰，李国荣，等.不育妇女心理因素的相关性研究[J].职业与健康，2002，18(9):79-81.
[153]李淑萍.滋肾疏肝法治疗卵巢储备功能下降35例疗效观察[J].四川中医，2004，22(12):62-63.
[154]严讳，何月萍.卵巢储备功能下降的中医证治思路和优势[J].第十次全国中医妇科学术大会论文集，2010:89-91.
[155]陈春晓.卵巢储备功能下降中医证候特征及内分泌特征的研究[D].导师：朱玲.广州中医药大学，2010:25-36.
[156]郑筱萸.中药新药临床研究指导原则[M].北京：中国医药科技出版社，2002，4:2.
[157]余凌，李惊子，王海燕.黄芪当归在肾脏疾病中的应用及其机制研究进展[J].中国中西医结合杂志，2001，21(5):396.
[158]王建红，王敏璋，伍庆华.菟丝子黄酮对应激大鼠卵巢内分泌的影响[J].中草药，2002，33(12)：1099-1101.
[159]崔瑛，颜正华，侯士良，等，论熟地黄的益智作用与研究思路[J].中国中药杂，2002，27(6)：404-406.
[160]倪艳.山茱萸的研究进展.中药研究通讯，1990，(总34):70.
[161]山原条二.现代东洋医学[M]，1986，(3):51-53
[162]臧莲碧，郑怡健.山茱萸抗衰老实验研究.浙江中医学院学报[J]，1993，17(5):34.
[163]项平.七种中药抗老作用的实验观察[J]，辽宁:中医杂志，1982，24（3）:44.
[164]王淑兰，李淑莲，董祟田，等.枸杞子等八种中药提取液对体外培养细胞和小鼠腹腔巨噬细胞影响的实验研究[J].白求恩医科大学学报，1990,16(4)：325-328.
[165]杨铁虹，贾敏，梅其炳.当归多糖对小鼠免疫功能的调节作用[J].中成药，2005，27(5)：563-565.
[166]韩涛，王宝恩，马学梅.复方中药对肝星状细胞胶原合成与降解的影响[J].天津医药，2001，29(11):671-673.
[167]李秋怡，干国平，刘炎文.川芎的化学成分及药理研究进展[J].时珍国医国药，2006，17（7）：1298-1299.
[168]金若敏，陈兆善，陈长勋，等.益母草治疗痛经机制探索[J].中国现代应用药学，2004，21(2)90-93.
[169]王立，张国斌段妍君，等.益母草胶囊抗炎镇痛作用的研究[J].湖北中医杂志，2005，27(8)53-54.
[170]丁伯平，熊莺，徐朝阳，等.益母草碱对急性血瘀证大鼠血液流变学的影响[J].中国中医药科技，2004，11(1)36-37.
[171]丁伯平，熊莺，徐朝阳，等.益母草注射液对失血性休克大鼠淋巴微循环的作用[J].陕西医药，2004，25(8)759.
[172]曹玫，张洪，张晓燕，等.香附的药理活性作用研究进展[J].药物流行病学杂志，2010，19(2)：111-113.
[173]Bernard L，Andre T， Irene Z，et al.Administration of Cyperusrotundas Tubers Extract prevents Weight Gain in Obese Zuckerrats [J].Phytother Res，2007，21（8）:724-730.
[174]Soumaya K，Mohamed BS，I lef L，et al.In vitro evaluation ofantibacterial，antioxidant，cytotoxic and apoptotic activitiesof the tubers infusion and extracts of Cyperus otundus [J].Bioresource Techno10gy，2008，99（18）:9004-9008.
[175]张发初，张耀德，刘绍光.香附子之药理研究第一次报告：南京市香附子流浸膏对于子宫之作用[C].药理研究报告，1985,5(2)：148.
[176]奚明.促黄体汤对假孕大鼠卵巢轴功能影响仁[J].中西医结合杂志，1992，12(8):476.
[177]蔡春环.高促性腺激素闭经22例分析[J].中原医刊，2002，(6)29：35-36.
[178]程湘，陈止琼，谢荣凯，等.盐酸氟两汀联合雌激素治疗绝经期抑郁症的临床观察[J].重庆医学，2005，34(5):721～722，724.
[179]卢莉，李建平，薛云珍，等.情绪反应、个性特征与月经失调的关系[J].中国心理卫生杂志，2005，19(3):156～158.
[180]孙玉芳，余立群，褚芳.长期心理应激对卵巢功能影响的实验研究[J].实验动物利学，2009，26(3）:27～28.
[181]罗仁.肾虚证流行病学调查报告[J].第一军医大学学报，1992，1(4)：357.
[182]林守清.激素补充治疗临床应用指南[J].实用妇产科杂志，2004，20(3):136-137.
[183]李力，薛晓琳，徐雯洁，等.“治未病”思想在亚健康防治中的意义[J].健康教育，2008，27(1)：76-77.
[184]冯文林，吴弥漫.《内经》“治未病”治则的思想探源[J].中国中医基础医学杂志，2006，12(12)：886-887.
[185]刘进，李国信，李丹.治未病学术思想探源及研究展望[J].中华中医药学刊，2008，6(26)：1309-1312.
[186]金光亮.《内经》未病概念与“治未病”理论探讨[J].北京中医药大学学报，2006，29(12)：804-806.
[187]许小凤，谈勇.卵巢储备功能低下中医证治路径探析[J].环球中医药，2010，3(5):325-327.
[188]韩兰香，杜娟，郭杨志等.丛慧芳辨治卵巢早衰治疗经验[J].四川中医，2012，30(2):16-17.
[189]金红花.益精补冲汤治疗卵巢储备功能低下55例临床观察[J].中医杂志，2008，49(9)：790.
[190]韩玉芬，程淑蕊，敬文娜，等.卵巢储备功能下降的预测及治疗[J].中国计划生育学杂志，2007，15(2):117.
[191]杨冬梓，杨炜敏.卵巢储备功能的检测方法[J].实用妇产科杂，2003，4(19):196.
[192]蔡连香，周佩云.从“治未病"角度探讨防治卵巢储备功能下降和卵巢早衰[J].浙江中医药大学学报，2009，33(5):713-714.
[193]谢京红，姜坤.中医治疗卵巢储备功能低下性月经不调临床观察[J].世界中医药，2008，3(6):338-339.
[194]张道云.肝郁气滞导致卵巢功能减退的理论探讨[J].中国中医药信息杂志，2005，12(10):92.
[195]王针织，俞超序.补肾化瘀祛痰方对雄激素致不孕大鼠卵巢局部调控因子的影响[J].中西医结合学报，2008，6(4):361-365.
[196]邓颖.自拟补肾调冲汤治疗高原地区卵巢早衰200例临床观察[J].四川中医，2009，27(5):92-93.
[197]韩连玉，叶亚智.抗卵衰冲剂治疗卵巢早衰36例临床研究[J].辽宁中医杂志，2008，35（3）：404.
[198]池雷，夏桂成.夏桂成教授调周疗法治疗月经病述要[J].实用医技杂志，2008，15（33）：4914.
[199]李晓燕.中药人工周期疗法治疗卵巢功能低下所致不孕症[J].辽宁中医学院学报，2002，4(2):133.
[200]郭金，张英杰，谭方信.益肾汤对初老雌性大鼠卵巢颗粒细胞超微结构的影响[J].成都中医药大学学报，2008，30(4):448-451.
[201]李淑萍，李玲.补肾调冲法治疗卵巢功能失调性不孕的实验研究[J].中国中医药信息杂志，2002，3(9):33-34.
[202]蔡立荣，李大金，孙晓溪.补肾活血方对小鼠实验性卵巢早衰防治作用的研究[J].中国中西医结合杂志，2001，2(21):126-129.
[203]朱玲，罗颂平，许丽绵.左归丸对免疫性卵巢早衰小鼠抗卵巢抗体的影响[J].现代中西医结合杂志，2006，25(4):435-438.
[204]朱玲，罗颂平，许丽绵.左归丸对小鼠自身免疫性卵巢损伤的保护作用[J].中国中两医结合杂志，2005，10(25):920-924.
[205]黄菊，罗丽莉，傅玉才，等.淫羊藿试对大鼠早期卵巢卵泡发育和卵母细胞凋亡影响的初步研究[J].中国现代医学杂志，2007，17(5):523-527.
[206]王翠霞，陈莹.补肾复方对初老大鼠卵巢颗粒细胞凋亡相关蛋白Bcl-2/Bax表达的影响[J].中医药学刊，2005，8(23):1402-1403.
[207]李军，王翠霞，陈莹.补肾复方延缓雌性大鼠卵巢早衰的实验研究[J].辽宁中医杂志2007，5(3):681-683.
[208]沙桂娥，赵文民.针灸治疗卵巢早衰34例临床观察[J].中国针灸1999，19(4):199-201.
[209]陈瑞雪，李艳红，马晓晶等.电针治疗卵巢早衰的疗效观察[J].中国中医基础医学杂志，2009，15(3):208.
[210]周佩云，黄欲哓，吴五香.蔡连香教授采用中药内服外用治疗POF经验[J].中华中医药杂志，2010，25(10):1613-1615.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |